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1. Introduction 
 
1.1 Symbiosis 
Microorganisms arose long before the appearance of the first multicellular organisms. 
When latter came into existence, their bodies provided new, persistent, stable and nutrient 
rich habitats for the microbes. As a result, large organisms have been inhabited by 
microorganisms at all times during their evolution (79). The most important of these 
interactions is probably the evolution of the eukaryotic organelles. More than 1.5 billion 
years ago, the cyanobacterial and alpha – proteobacterial ancestors of today‟s plastids and 
mitochondria established a stable symbiosis with their host cell, thereby giving rise to 
modern eukaryotes (72).  
The term „symbiosis“ was defined by de Bary in 1879 (24) as „the living together of two 
differently named organisms“, independent of effects on the organisms involved and 
thereby including mutualism, parasitism and commensalism. A microbial symbiont can 
evolve to benefit its host, because by survival of its host it ensures survival of its current 
habitat. On the other hand symbiosis might also result in damage to the host (101). Today, 
a huge number of symbioses between eukaryotes of different hierarchical levels and 
bacteria is known, indicating the tremendous importance of symbiotic interactions for life 
on Earth. 
 
1.2 The discovery of novel chlamydia-like bacteria as symbionts of 
amoebae  
Free-living amoebae are ubiquitous protozoa that feed on a wide variety of 
microorganisms, including bacteria. However, some bacteria have developed strategies to 
survive uptake by amoebae and to multiply within them. Amoebae are therefore 
considered as “Trojan horses of the microbial world”, acting as vectors and reservoirs for 
several bacteria, including numerous human pathogens, such as Legionella pneumophila 
and Listeria monocytogenes (52). In a study by Fritsche et al. (34), about 25% of studied 
Acanthamoeba isolates were shown to harbour intracellular bacteria. As most of these 
bacteria could not be isolated and cultivated in cell-free media, they were considered as 
obligate intracellular endosymbionts. In 1997, chlamydia-like bacteria were found as  
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 Fig. 1: Diversity in the phylum Chlamydiae. Phylogenetic tree of known chlamydiae based on 
comparative 16S rRNA analysis. From (50) 
 
endosymbionts in amoebae (3, 12) and a later study identified 5% of amoeba 
endosymbionts as chlamydia-like bacteria (35). When additionally new chlamydia-like 
bacteria were found as contaminants in a laboratory cell culture (62) and in an aborted 
bovine foetus (95), this changed the picture of chlamydial diversity dramatically.  
Before the discovery of these chlamydia-like bacteria, chlamydiae were believed to be a 
small group of closely related pathogens that formed a phylogenetically well separated  
phylum in the domain bacteria that contained a single family, the Chlamydiaceae, within 
a single order, the Chlamydiales. This family harbours important pathogens like 
Chlamydia trachomatis, the most frequently sexually transmitted pathogen (118) and the 
world‟s leading cause of preventable blindness (119), or Chlamydophila pneumoniae, 
causative agent of human respiratory diseases, which is suggested to play also a role in 
artheriosclerosis and coronary heart disease (8, 66). 
The discovery of novel chlamydia-like bacteria, also termed „environmental chlamydiae‟ 
in order to distinguish them from the Chlamydiaceae or „clinical chlamydiae‟, lead to a 
significant expansion of the phylum Chlamydiae. Based on 16S rRNA sequence analysis, 
it currently contains eight families. Additionally to the Chlamydiaceae, the order 
Chlamydiales now consists of the families Parachlamydiaceae, Waddliaceae, 
Simkaniaceae, Rhabdochlamydiaceae, Piscichlamydiaceae, Clavochlamydiaceae and 
1. Introduction 
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Criblamydiaceae (Fig. 1). As the diversity is thought to be even larger based on detection 
of phylogenetically diverse rRNA sequences most similar to known chlamydiae in 
various habitats, the number of families might even increase in the next years (50, 53) 
The pathogenic potential of environmental chlamydiae is so far not clear. Although there 
is some evidence that environmental chlamydiae might be involved in human diseases (5, 
21) (42), more research is needed to show a causal relationship between chlamydia-like 
bacteria and human disease. However, there is considerable evidence for environmental 
chlamydiae infecting animals and thereby causing abortion in cattle (94) and 
epitheliocystis in fish (28, 63). 
When the genome of Protochlamydia amoebophila, an amoeba endosymbiont, was 
sequenced in 2004, it was found to be nearly twice as large as that of clinical chlamydiae. 
The genome of P. amoebophila was found to harbour reduced central metabolic and 
biosynthetic pathways, comparable to genomes of clinical chlamydiae and other obligate 
intracellular bacteria, but to encode a complete tricarboxylic acid cycle in contrast to 
chlinical chlamydiae.  Comparative genome analysis of members of the clinical 
chlamydiae and this member of the environmental chlamydiae showed that their last 
common ancestor lived about 700 million years ago and was already adapted to 
intracellular survival in early eukaryotes (51). Recent studies indicate that this ancestor 
might also have played a fundamental role in the evolution of plastids. The discovery of 
genes of chlamydial origin in plant genomes and a high number of plant- and 
cyanobacteria-like genes in chlamydial genomes lead to the suggestion that chlamydiae 
were involved in establishing a stable interaction between the ancestor of plants and its 
cyanobacterial symbiont, thereby giving rise to modern plants (56, 82). 
 
The chlamydial developmental cycle 
All known members of the phylum Chlamydiae  share a characteristical biphasic lifecycle 
that alternates between an infectious extracellular form termed elementary body (EB) and 
an intracellular replicative form, the reticulate body (RB) (reviewed in 1). EBs are 
metabolically inactive and have a very rigid, osmotically stable cell wall that allows 
survival in harsh environments. In contrast, RBs are metabolically active and more fragile 
than EBs (43). In addition to these two developmental forms, the existence of crescent 
bodies (CB) has been suggested for Parachlamydia acanthamoeba. This form is regarded 
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as an additional infective developmental stage, whose presence has been associated with 
prolonged incubation time (40) 
At the beginning of the developmental cycle an infectious EB attaches to a host cell and is 
taken up by the host. Upon entry, chlamydiae reside within a host-derived vacuole termed 
inclusion. In this inclusion, the EBs differentiate into RBs, which divide by binary fission. 
After several rounds of replication, RBs re-differentiate into EBs and leave the host cell 
by either lysis of the host or exocytosis (59) in order to infect new host cells (Fig. 2). 
 
Fig. 2: The developmental cycle of chlamydia–like bacteria. Infectious EBs attach to their host cell 
and are internalized (A). Inside the host cell, EBs differentiate to RBs and multiply within large or 
single cell inclusions (B). After re-differentiation to EBs (C), chlamydiae leave their host by exocytosis 
or lysis of the cell (D and E). Modified from (50). 
 
1.4 The chlamydial inclusion 
The vacuole in which chlamydiae reside within their host cell is unique among 
intracellular bacteria and has been studied intensively for members of the Chlamydiaceae, 
but not for other members of the Chlamydiales. 
After uptake of the bacteria, the chlamydial inclusion does not enter the endocytic 
pathway, but separates itself from this pathway at an early stage of development (98). Rab 
GTPases, known regulators of intracellular trafficking, were shown to be recruited to the 
chlamydial inclusion and might be involved in the escape from the endocytic pathway 
(23, 96). Expansion of the inclusion occurs by hi-jacking host-vesicles containing 
1. Introduction 
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sphingomyelin (41) and recently also transport of lipid droplets to the inclusion 
membrane has been shown (17). Active participation of chlamydiae is needed during 
these events, as the uptake of sphingomyelin and the escape from the endocytic pathway 
require chlamydial gene expression (99).  
As chlamydiae live intracellularly, they depend on their host for the acquisition of 
nutrients. Fusion of the inclusion with vesicles of the phagolysosomal pathway is thought 
to be the main source for nutrients. All these interactions of chlamydiae with their host 
cell highlight the necessity of communication and transport mechanisms between bacteria 
and host cell across the barrier of the inclusion membrane. 
Rockey et al. (93) identified the first chlamydial protein in the membrane of the host-
derived inclusion, IncA, in 1995. Besides IncA, several other inclusio nmembrane 
proteins (Incs) have been identified in the last years by in silico approaches and for a 
subset of these proteins, localization in the inclusion membrane has been demonstrated 
(e.g. 68, 69). All Inc-proteins known so far share no discernable homology on the amino-
acid  level, but contain a characteristic bilobed hydrophobic domain of 50-80 amino 
acids. They are thought to be injected in the chlamydial inclusion membrane by the type-
three-secretion system that is found in all chlamydiae (108).  
A function is only known for few of these proteins. IncA plays a role in the fusion of 
chlamydial inclusions (26), probably by means of a SNARE-like-motif that was identified 
in this protein (26, 27). This case describes the first SNARE mimicry identified in a 
bacterium and supports the role of IncA for the fusion of inclusions, as SNARE 
signatures are known to play an essential role in targeting and fusion of vesicles in 
eukaryotes. Two Inc-proteins were reported to interact with host-cell rab GTPases, 
suggesting a role of these proteins in intracellular trafficking (23, 96).  IncG is known to 
bind to the host-protein 14-3-3-beta, an interaction that is speculated to inhibit apoptosis 
of cells infected with C. trachomatis (100, 112).  
Recently, putative Inc-proteins have also been identified in the chlamydia-like bacterium 
P. amoebophila by in silico analysis (47). 
Although the function of most Inc-proteins is not known, these proteins seem to be 
central regulators of bacteria-host interactions and play an important role in 
communication between chlamydiae and their host cells and thereby in survival of 
chlamydiae within their host. 
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1.5 The chlamydial cell envelope 
Chlamydiae have a cell envelope similar to that of other Gram-negative bacteria, 
consisting of an inner membrane, a periplasmic space and an outer membrane.  
In contrast to other Gram-negative bacteria, chlamydiae seem to lack peptidoglycan, 
although the presence or absence of peptidoglycan is controversially discussed (75). 
Genome analysis showed the presence of a truncated pathway for the synthesis of 
peptidoglycan. Transcription of the genes of this pathway was shown by microarray 
analysis (73). Additionally, chlamydiae are susceptible to treatment with antibiotics that 
inhibit the peptidoglycan synthesis (81). But until now, detection of N-acetylmuramic 
acid, a key constituent of peptidoglycan, has not been possible in chlamydiae (75). 
Stability is thought to be conferred to chlamydial cell walls by cysteine-rich proteins of 
the outer membrane instead. These proteins are regarded as functional equivalent of 
peptidoglycan in chlamydiae (43) and are discussed below in further detail. 
 
1.5.1 Outer membrane proteins of Chlamydiaceae 
Proteins in the outer membrane are of great importance as they are involved in attachment 
to the host cell, uptake of nutrients, removal of waste and in case of the chlamydiae also 
in the differentness of EBs and RBs. 
In the Chlamydiaceae, the two cysteine-rich proteins OmcB (60 kDa) and OmcA (12 
kDa) are thought to provide rigidity to the cell wall of the EB and to render it osmotically 
stable. These two proteins harbour a high number of cysteines that are extensively cross 
linked by disulfide bridges in the EB cell envelope. Upon entry of the EB into the host 
cell, these disulfide bridges are reduced, resulting in osmotically fragile RBs (44). This 
mechanism is of great importance to chlamydiae as it allows them to divide 
intracellularly, when cross links are reduced, and to survive extracellularly when proteins 
are cross linked (43). Cross linking during conversion from RBs to EBs is thought to 
occur either spontaneously when the host cell is lysed (45) or late in the developmental 
cycle by an enzymatic reaction before host cell lysis (88), but the exact mechanism is not 
known.  
The small cysteine-rich protein OmcA is a lipoprotein and thought to be anchored in the 
inner leaflet of the outer membrane (43). The large cysteine-rich protein, OmcB, was long 
thought to be localized to the periplasm, where it was proposed to form a stabilizing 
lattice by inter- and intramolecular disulfide bridges (83, 88). Therefore, it was not 
1. Introduction 
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regarded as a true member of the outer membrane, an assumption encouraged by its 
solubility in sarcosyl in contrast to other outer membrane proteins of Chlamydiaceae (30). 
However, there is strong evidence now for a localization of OmcB to the outer membrane 
of C. trachomatis and C. pneumoniae and involvement of this protein in heparin-binding 
on the surface of eukaryotic cells (31, 78, 103). 
Other well characterized outer membrane proteins are the major outer membrane protein 
(MOMP) that forms the chlamydial outer membrane complex (COMC) together with 
OmcA and OmcB and is described in more detail below, and the members of the 
polymorphic outer membrane protein (POMP) family.  
 
Fig. 3: Model of the cell envelope of Chlamydiaceae. OmcB is shown to be localized in the periplasmic 
space and the outer membrane. Modified from (47). 
 
The chlamydial POMPs are a family of autotransporters (48) with heterologous primary 
amino acid sequence that can be recognized by two repeated sequence motifs. The 
unusually high polymorphism of these proteins is suggested to be due to selective 
pressure from the immune system (37) and might contribute to tissue specificity of 
different C. trachomatis disease groups (38, 105). Members of this family were shown to 
play a role in attachment to host cells (115) and in expansion of the chlamydial inclusion 
(61). 
 
1.5.2 The major outer membrane protein 
The outer membrane provides a barrier against harmful environmental factors, but also a 
barrier to the uptake of nutrients into the cell and the removal of waste from the cell. 
Permeability of the membrane is conferred by specific and unspecific transporters. 
  1. Introduction 
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Unspecific transporters are termed porins. Porins are water-filled channels that allow the 
passage of small molecules with an exclusion limit of typically 600 Da and extremes of 
5,000 Da, showing a transport rate proportional to the concentration gradient (117). 
The major component of the chlamydial outer membrane is the major outer membrane 
protein (MOMP), a porin that is thought to make up about 60% of the chlamydial outer 
membrane (15). This 40 kDa protein has been intensively studied as it was shown to be 
an important chlamydial antigen that elicits a strong immune response (15). In EBs, 
MOMP is highly cross linked and mostly present as a trimer, whereas it is found mostly 
in its monomeric form in RBs (44). It has been suggest for a long time, that trimers of 
MOMP are held together by disulfide bonds (87). More recent studies suggest that 
although disulfide bonds are present between peptides of the trimers, they are not required 
for its folding, its outer membrane insertion or to stabilize it (32, 110).  
The porin function of MOMP in different strains has been demonstrated by different 
approaches. Bavoil et al. (6) were the first to show that preparations of the COMC have 
porin activity by liposome swelling assays. Opening of the pore appeared to be regulated 
by disulfide bonds, because treatment of the isolated COMC with reducing agents 
resulted in a strong increase in channel activity, a mechanism also thought to occur after 
entry of chlamydiae into the host cell. The function of  MOMP as porin was confirmed by 
lipid bilayer measurements using purified native and recombinant MOMP (32, 110, 121), 
but opening of the pore by reducing agents could not be shown for these preparations. 
This suggests that the effect observed by Bavoil  was either due to other porins present in 
the purified COMC or to disulfide bonds formed between MOMP and other members of 
the outer membrane that are not present in preparations of purified MOMP. 
MOMP forms a pore consisting of 16 antiparallel beta-sheets that form a barrel-like 
structure typical of porins of Gram-negative bacteria (110). MOMP is found in trimeric 
conformation in the outer membrane (74, 121). The barrel consists of five well conserved 
transmembrane domains that are connected to each other by four variable, surface 
exposed loops (4, 126). Removal of these loops has no influence on folding or 
incorporation of MOMP into the outer membrane of Escherichia coli, in contrast to 
removal of the transmembrane domains (32, 57). The four variable domains that are 
exposed to the surface show great variations in sequence (102) and reaction of MOMP 
with different antibodies targeting these variable regions is used for serovar typing in C. 
trachomatis (113, 126).  
1. Introduction 
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Antibodies against the major outer membrane protein were reported to neutralize 
infectivity of chlamydiae (16, 92, 106) and to protect mice from abortion after infection 
with chlamydiae (25, 91). Although it seems to be a promising candidate, development of 
a vaccine based on MOMP has not been successful yet. Vaccines based on recombinant 
and therefore non-native MOMP result in only partial protection (91).Vaccines containing 
native MOMP have been shown to be protective against chlamydial disease (91, 111), but 
high variation in parts of MOMP-sequence leads to difficulties in preparing a general 
vaccine and additionally, isolation of high quantities of the native form of MOMP is not 
practicable at the moment. 
 
1.5.3 PorB 
In 2000, a protein with weak sequence similarity to MOMP was identified in the genome 
of C. trachomatis. Localization of this protein to the chlamydial outer membrane complex 
and pore-forming activity of this protein, termed PorB, was demonstrated. Diffusion of 
sugars and amino acids was not as efficient for PorB as for MOMP. As PorB was only 
observed in small amounts in the COMC, the authors of the study suggested a more 
specific function of this porin compared to MOMP. Although PorB is present in much 
smaller amounts than MOMP, antibodies targeting this protein neutralized infectivity of 
C. trachomatis in vitro (65). 
 
1.5.4 Outer membrane proteins of P. amoebophila 
In contrast to Chlamydiaceae, little is known about the composition of the outer 
membrane of chlamydia-like bacteria. After sequencing the genome of the first member 
of the environmental chlamydiae in 2004 (51), only a homologue of the large cysteine-
rich protein OmcB was found. An OmcA homologue was detected due to its position in 
the genome and the high amount of cysteines in this gene. No homologue of MOMP, 
PorB or members of the POMPs were found in P. amoebophila.  
A recent study identified 38 outer membrane proteins of P. amoebophila by combining 
1D and 2D gel electrophoresis of outer membrane fractions with mass spectrometry (47). 
The identified proteins included the P. amoebophila OmcB, pc0616, and OmcA, pc0617. 
In this study, a putative porin family was identified consisting of four proteins. Proteins of 
this family share an amino acid sequence identity of 22-28 % and have no homologues in 
other organisms except for P. acanthamoeba, a close relative of P. amoebophila. Two of 
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these proteins, pc1489 and pc1077, were present in high amounts in outer membrane 
fractions. Both were predicted to form a beta-barrel by in silico analysis and found to 
encode predicted signal peptides. Based on their high abundance and their putative 
function as porins, these two proteins were suggested to act as a functional replacement 
for MOMP in P. amoebophila, and form the COMC of P. amoebophila by interactions 
with pc0616 and pc0617. Pc0978 could be an additional part of the COMC, as it was 
found as frequently as pc0616 in outer membrane preparations and has a high number of 
cysteines. Therefore, it might be involved in disulfide-cross linking with other proteins to 
provide stability to the outer membrane of P. amoebophila. 
 
Fig. 4: Model of the outer membrane of P. amoebophila as proposed by Eva Heinz (47). 
 
1. 6 Aims of this study 
The outer membrane of bacteria plays an important role in the attachment to host cells, 
uptake of substances from the host cell and in the case of chlamydiae also in the 
differentness between EBs and RBs.  
The major outer membrane protein is the most abundant component in the cell envelope 
of members of the Chlamydiaceae. The outer membrane of P. amoebophila, a member of 
the recently discovered environmental chlamydiae, seems to differ substantially from that 
of Chlamydiaceae. The most interesting feature is the absence of almost all main 
components of the chlamydial outer membrane, including MOMP and POMPs. MOMP 
was suggested to be replaced by the two putative porins pc1077 and pc1489. In silico 
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analysis predicted the presence of a signal peptide and localization to the outer membrane 
for these two proteins.  Structure prediction indicated formation of a beta-barrel structure, 
a typical feature of porins of Gram-negative bacteria (47).  
The aim of this study was to characterize the putative porin pc1489 concerning its 
localization, its expression during the developmental cycle and its putative function as a 
porin in P. amoebophila.  
 
In the second part of this study, the localization of putative Inc-proteins of P. 
amoebophila was investigated. Proteins in the inclusion membrane of P. amoebophila are 
of exceptionally great interest, as this organism forms single cell inclusions in contrast to 
large inclusions containing many bacteria observed in members of the Chlamydiaceae. It 
is quite likely that differences in Inc proteins account for this. Additionally, Inc proteins 
might play an important role in survival of P. amoebophila in amoebae after 
internalization. 
  2. Material and Methods 
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2. Material and Methods 
 
2.1 Technical equipment  
 
Table 1: Technical equipment used in this study 
Equipment Company 
Agarose gel electrophoresis apparature Sub–Cell GT  Bio-Rad Laboratories GmbH, Munich, Germany 
CCD camera AxioCam HRc Carl Zeiss MicroImaging GmbH, Jena, Germany 
Centrifuges: 
Centrifuge 5840 R 
OptimaTM L-100 XP ultracentrifuge 
 
Eppendorf AG, Hamburg, Germany 
Beckman Coulter, Inc., Palo Alto, CA, USA 
Concentrator 5301 Eppendorf AG, Hamburg, Germany 
Electroporator Micro PulserTM   Bio-Rad Laboratories GmbH, Munich, Germany 
Devices for gelelectrophoresis: 
Electrophoresis cell (Sub-Cell GT) 
Electrophoresis power supply (PowerPac Basic) 
 
Bio-Rad Laboratories GmbH, Munich, Germany  
Bio-Rad Laboratories GmbH, Munich, Germany 
icycler Thermal cycler Bio-Rad Laboratories GmbH, Munich, Germany 
Microbiological incubator KB 115 Binder GmbH, Tuttlingen, Germany 
Laminar flow hood, model 1.8 Holten, Jouan Nordic, Allerod, Denmark 
Magnetic stirrer RCT basic IKA® Werke GmbH & Co.KG, Staufen, Germany 
Microscopes: 
Inverse microscope Axiovert 25  
Epifluorescence microscope Axioplan 2 imaging 
Confocal laser scanning microscope LSM 510 Meta 
 
Carl Zeiss MicroImaging GmbH, Jena, Germany 
Carl Zeiss MicroImaging GmbH, Jena, Germany 
Carl Zeiss MicroImaging GmbH, Jena, Germany 
Mixing Block MB-102 Biozym Scientific GmbH, Hessisch Oldendorf, 
Germany 
NanoDrop® ND-1000 UV/Vis spectrophotometer NanoDrop Technologies Inc., Wilmington, DE, 
USA 
Neubauer counting chamber Paul Marienfeld GmbH & Co KG, Lauda-
Königshofen, Germany 
pH meter inoLab pH Level 1 Wissenschaftlich technische Werkstätten (WTW) 
GmbH & Co.KG, Weilheim, Germany 
Scales: 
OHAUS®  Analytical Plus balance 
Sartorius BL 3100 
 
Ohaus Corporation, Pine Brook, NJ, USA 
Sartorius AG, Göttingen, Germany 
ScannerEpson Expression 1680 Pro  Epson Deutschland GmbH, Meerbusch, Germany 
Devices for SDS-PAGE analysis:  
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Mini-PROTEAN Casting Stand 
Mini-PROTEAN Tetra Cell 
Bio-Rad Laboratories GmbH, Munich, Germany 
Bio-Rad Laboratories GmbH, Munich, Germany 
Sonicator Bandelin Sonoplus HD2070 Bandelin electronic GmbH & Co.KG, Berlin, 
Germany 
Sonotrode Bandelin Sonoplus UW 2070 Bandelin electronic GmbH & Co.KG, Berlin, 
Germany 
Spectral photometer SmartSpecTM  3000 Bio-Rad Laboratories GmbH, Munich, Germany 
TE77 semi-dry transfer unit  GE Healthcare Bio-Sciences AB, Uppsala, Sweden 
Thermostatic circulator MultiTempTM III GE Healthcare Bio-Sciences AB, Uppsala, Sweden 
Transilluminator  Biostep GmbH, Jahnsdorf, Germany 
Ultrasonic Cleaner SC100T VWR International bvba/sprl, Leuven, Belgium 
UV sterilizing PCR workstation PeqLab Biotechnologie GmbH, Erlangen, Germany 
Water baths: 
DC10 
GFL® type 1004 
 
Thermo Haake GmbH, Karlsruhe, Germany 
Gesellschaft für Labortechnik GmbH, Burgwedel, 
Germany 
Water purification system MILLI-Q® biocel  Millipore GmbH, Vienna, Austria 
Watervapour high pressure autoclaves: 
Varioclav® 135 S h+P 
Varioclav® 25 T H+P 
 
H+P Labortechnik GmbH, Oberschleißheim, 
Germany H+P Labortechnik GmbH, 
Oberschleißheim, Germany 
 
2.2 Expendable items and kits 
 
Table 2: Expandable items used in this study 
Expandable item Company 
25 cm2 Tissue culture flasks Asahi Techno Glass Corporation, Iwaki Glass Co., 
Ltd., Funabashi-City, Japan 
500 cm2 Tissue culture flasks Nunc, Roskilde, Denmark 
Cellulose acetate membrane filters (0.45 µm pore 
size, 25 mm diameter) 
Sartorius Stedim Biotech GmbH, Göttingen, Germany 
Cover glasses 24 x 60 mm Paul Marienfeld GmbH & Co.KG, Lauda-
Königshofen, Germany 
Electroporation cuvette (0.2 cm) Bio-Rad Laboratories GmbH, Munich, Germany 
Glass beads (0,75-1.0 mm) Macherey-Nagel GmbH&Co.KG, Karlsruhe, 
Germany 
Greiner tubes (15 ml, 50 ml) Greiner Bio-One GmbH, Frickenhausen, Germany 
IsoporeTM polycarbonate membrane filters (0.22 
µm pore size, 25 mm diameter, black) 
Millipore GmbH, Vienna, Austria 
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Microscope slides (76 x 26 mm) Carl Roth GmbH & Co KG, Karlsruhe, Germany 
Microscope slides, 10 well Paul Marienfeld GmbH & Co KG, Lauda-
Königshofen, Germany 
Multiwell dishes, polystyrene (24 wells) Nunc, Roskilde, Denmark 
 
Needles Sterican® (ø 0,45 x 25 mm, ø 0,90 x 40 
mm), single use, sterile 
B.Braun Melsungen AG, Melsungen, Germany 
PCR tubes (0.2 ml) Biozym Scientific GmbH, Hessisch Oldendorf, 
Germany 
Pipette Tipps (various sizes) Carl Roth GMbH  Co.KG, Karlsruhe, Germany 
Plastic cuvettes Greiner Bio-One GmbH, Frickenhausen, Germany 
Plastic pipettes (10 ml, 2 ml), single use, sterile Barloworld Scientific Ltd., Staffordshire, UK 
Polyvinylidene fluoride membrane (Hydrobond P) GE Healthcare Bio-Sciences AB, Uppsala, Sweden 
Reaction tube (1.5 ml)  GenXpress Service & Vertriebs GmbH, Wiener 
Neudorf, Austria 
Reaction tube (2 ml)  Greiner Bio-One GmbH, Frickenhausen, Germany 
Round coverslips (12 mm diameter)  Carl Roth GmbH & Co., Karlsruhe, Germany 
Syringe (1 ml) Inject® - F 1ml, single use, sterile B.Braun Melsungen AG, Melsungen, Germany 
Syringe ( 5 ml) Omnifix® single use, sterile B.Braun Melsungen AG, Melsungen, Germany 
Syringe filter, single use, sterile, 0.20 µm pore 
size 
Asahi Techni Glass Corporation, Iwaki Glass Co., 
Ltd., Funabashi-City, Japan 
Syringe filter, single use, sterile, 1.20 µm pore 
size 
 Sartorius AG, Goettingen, Germany 
Ultracentrifuge tubes Beckham Coulter, Inc. Paolo Alto, CA, USA 
Whatman® Chromatography Paper 3MM Chr Whatman Internation Ltd., Maidstone, UK 
 
Table 3:Kits used in this study 
Kit Company 
DNeasy Blood & Tissue Kit QIAgen, Hilden, Germany 
BCA Protein Assay Kit Thermo Scientific Pierce Protein Research Products, 
Waltham, Massachusetts, USA 
Western Lightning Chemiluminesence Plus Kit Perkin Elmer, Waltham, Massachusetts, USA 
HiTrap™ IgY Purification HP Column GE Healthcare Bio-Sciences AB, Uppsala, Sweden 
Qiaquick PCR purification Kit QIAgen, Hilden, Germany 
Vivapure Q Mini H Spin column Sartorius AG, Göttingen, Germany 
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2.3 Chemicals and enzymes 
 
Table 4: Chemicals used in this study 
Chemical Company 
4´,6-diamidino-2-phenylindole (DAPI) Laktan Chemikalien und Laborgeräte GmbH, Graz, 
Austria 
Aceotnitrile Sigma-Aldrich Chemie GmbH, Steinheim, 
Germany 
Acetic acid  Carl Roth GmbH & Co.KG, Karlsruhe, Germany 
LE Agarose  Biozym Scientific GmbH, Hessisch Oldendorf, 
Germany 
Ammonium bicarbonate Fluka Chemie AG, Buchs, Switzerland 
Ammonium persulfate (APS) GE Healthcare Bio-Sciences AB, Uppsala, Sweden 
Ampicillin Sigma-Aldrich Chemie GmbH, Steinheim, 
Germany 
Boric acid Carl Roth GmbH & Co KG, Karlsruhe, Germany 
Bovine serum albumin (BSA) Carl Roth GmbH  Co.KG, Karlsruhe, Germany 
Brilliant Blue G-250 Carl Roth GmbH & Co KG, Karlsruhe, Germany 
Brilliant Blue R-250 Carl Roth GmbH & Co KG, Karlsruhe, Germany 
Bromphenol blue  Sigma-Aldrich Chemie GmbH, Steinheim, 
Germany 
Calcium chloride dihydrate  Carl Roth GmbH & Co KG, Karlsruhe, Germany 
Citifluor AF1 Agar Scientific Ltd., Stansted, UK 
Coomassie brillant blue G-250 Carl Roth GmbH  Co.KG, Karlsruhe, Germany 
Disodiumhydrogenphosphate dihydrate (Na2HPO4 x 
2H20) 
Carl Roth GmbH  Co.KG, Karlsruhe, Germany 
Dithiothreitol (DTT) Fluka Chemie AG, Buchs, Switzerland 
Ethanol absolute  AustrAlco Österreichische Alkoholhandels GmbH, 
Spillern, Austria 
Ethidium bromide (EtBr) Fluka Chemie AG, Buchs, Switzerland 
Ethylenediamine-tetraaceticacid (EDTA) Carl Roth GmbH & Co KG, Karlsruhe, Germany 
Ferrous ammonium sulfate hexahydrate Sigma-Aldrich Chemie GmbH, Steinheim, 
Germany 
Ficoll® 400 Sigma-Aldrich Chemie GmbH, Steinheim, 
Germany 
Formaldehyde (37% (w/w)) Carl Roth GmbH  Co.KG, Karlsruhe, Germany 
Gastrografin® Schering Austria GmbH, Vienna, Austria 
Glucose Carl Roth GmbH  Co.KG, Karlsruhe, Germany 
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Glycerol (87% (w/v))  Carl Roth GmbH  Co.KG, Karlsruhe, Germany 
Glycine  Carl Roth GmbH  Co.KG, Karlsruhe, Germany 
HEPES Carl Roth GmbH  Co.KG, Karlsruhe, Germany 
Hydrochloric acid (HCl) (37% (w/w)) Carl Roth GmbH  Co.KG, Karlsruhe, Germany 
Iodacetamide GE Healthcare Bio-Sciences AB, Uppsala, Sweden 
Isopropanol Carl Roth GmbH  Co.KG, Karlsruhe, Germany 
Magnesium sulfate heptahydrate Merck GmbH, Vienna, Austria 
Methanol Carl Roth GmbH  Co.KG, Karlsruhe, Germany 
Moviol 4-88 Sigma-Aldrich Chemie GmbH, Steinheim, 
Germany 
N,N,N´,N´-tetramethylethane-1,2-diamine (TEMED)  Fluka Chemie AG, Buchs, Switzerland 
N-octyl polyoxyethylene (n-octyl POE) BACHEM BIOCHEMICA GmbH, Heidelberg, 
Germany 
Paraformaldehyde (PFA) Sigma-Aldrich Chemie GmbH, Steinheim, 
Germany 
Proteose peptone Oxoid Ltd., Hampshire, England 
 
Rotiphorese® NF-Acrylamide/ 
Bisacrylamide-solution 30 % (29:1) 
Carl Roth GmbH  Co.KG, Karlsruhe, Germany 
Sodium chloride (NaCl) Carl Roth GmbH  Co.KG, Karlsruhe, Germany 
Sodium dihydrogen phosphate Mallinckrodt Baker B.V., Deventer, Holland 
Sodium dodecly sulfate (SDS)  Carl Roth GmbH  Co.KG, Karlsruhe, Germany 
Sodium hydroxide (NaOH) Carl Roth GmbH  Co.KG, Karlsruhe, Germany 
Sucrose Merck KGaA, Darmstadt, Germany 
Trifluoretic acid Fluka Chemie AG, Buchs, Switzerland 
Trishydroxymethlaminomethane (Tris-HCl) Carl Roth GmbH  Co.KG, Karlsruhe, Germany 
Trypticase Soy Broth Oxoid Ltd., Hampshire, England 
Trypsin gold powder Promega Corporation, Madison, USA 
TweenTM 20 Sigma-Aldrich Chemie GmbH, Steinheim, 
Germany 
Xylene cyanole FF Sigma-Aldrich Chemie GmbH, Steinheim, 
Germany 
Yeast extract Oxoid Ltd., Hampshire, England 
 
Table 5: Enzymes and and corresponding enzyme buffers used in this study 
Enzyme Company 
Benzonase® Nuclease Novagen, Darmstatd, Germany 
Buffer O Fermentas Inc., Hanover, MD, USA 
Lysozyme human (≥ 100 U/µg) Sigma-Aldrich Chemie GmbH, Steinheim, Germany 
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Taq DNA Polymerase (5U/µl)  Fermentas Inc. Hanover, MD, USA 
10 x Taq buffer Fermentas Inc. Hanover, MD, USA 
VspI (10 U/µl) Fermentas Inc., Hanover, MD, USA 
 
2.4 Organisms 
Table 6: Amoeba strains and endosymbionts used in this study 
Host Endoymbiont Source Reference 
Acanthamoeba 
castellanii Neff 
none American Type Culture 
Collection (ATCC), 
Manassas, VA, USA 
 
(86) 
Acanthamoeba 
castellanii Neff 
Protochlamydia 
amoebophila UWE25 
University of 
Washington, Seattle, USA 
(19, 36) 
Acanthamoeba  
sp. UWC1 
Parachlamydia 
acanthamoeba UV-7 
Wastewater treatment 
plant, Plattling, Germany 
(18, 35)  
Acanthamoeba  
sp. EI2 
Protochlamydia 
amoebophila sp. EI2 
Soil, Lower Austria, 
Austria 
(97) 
 
Table 7: Escherichia coli strains used in this study 
Strain Source Genotype Reference 
BL21 (DE3) Stratagene F-, ompT, hsdS(rB-mB-), gal, dem, 
λ(DE3) 
(116) 
 
2.5 Plasmids 
For expression of proteins in Escherichia coli BL21 (DE3) the vector pet16b was used 
(Novagen, Darmstadt, Germany). E. coli cells harbouring the plasmids listed in table 8 
were obtained from Eva Heinz (47). 
 
Table 8: Plasmids used in this study 
Plasmid Insert Weight of full 
length protein 
Weight of protein 
fragment 
Reference 
pet16b – pc03991 Fragment of pc0399 
(aminoacids 120 – 402) 
95.9 kDa 35 kDa (47) 
pet16b – pc 0156 Fragment of pc0156 
(aminoacids 1 – 180) 
35.1 kDa 23.5 kDa (47) 
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pet16b - pc1111 Fragment of pc1111 
(aminoacids 1 – 199) 
35.6 kDa 25.1 kDa (47) 
pet16b – pc0530 Fragment of pc0530 
(aminoacids 78 - 252) 
28.2 kDa 22.1 kDa (47) 
pet16b – pc0577 Fragment of pc0577 
(aminoacids 2 - 201) 
22.8 kDa 25.3 kDa* (47) 
* The higher weight of the protein fragment compared to the full length protein results from a 
His-Tag added to the fragment by cloning in the vector pet16b. 
 
2.6 Antibodies 
2.6.1 Primary antibodies 
 
Table 9: Primary antibodies used in this study 
Antibody Antigen Source of 
antibody 
Dilution Reference 
anti-Pam P. amoebophila elementary bodies rabbit 1 : 2,000 (47) 
anti-Pam P. amoebophila elementary bodies chicken 1 : 2,000 (47) 
anti-pc0399-1 Fragment of pc0399  
(aminoacids 120 – 402) 
rabbit 1 : 1,000 (47) 
anti-pc0156 Fragment of pc0156  
(aminoacids 1 – 180) 
rabbit 1 : 500 (47) 
anti-pc1111 Fragment of pc1111 
(aminoacids 1 – 199) 
rabbit 1 : 100 (47) 
anti-pc0530 Fragment of pc0530 
 (aminoacids 78 - 252) 
rabbit 1 : 20 (47) 
anti-pc0577 Fragment of pc0577  
(aminoacids 2 - 201) 
rabbit 1 : 20 (47) 
preI pc0399-1 
(pre-immune serum) 
none rabbit 1 : 1,000 (47) 
preI pc0156 
(pre-immune serum) 
none rabbit 1 : 500 (47) 
preI pc1111 
(pre-immune serum) 
none rabbit 1 : 100 (47) 
preI pc0530 
(pre-immune serum) 
none rabbit 1 : 20 (47) ) 
preI pc0577 
(pre-immune serum) 
none rabbit 1 : 20 (47) 
anti-Hsp60 Hsp60 of Chlamydophila caviae guinea-pig 1 : 2,000 (125) 
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GPIC 
anti-pc1489 pc1489 purified from EBs chicken 1 : 2,000  
preI pc1489 
(pre-immune serum) 
none chicken 1 : 2,000  
anti-Cld Chloride dismutase purified from 
"Candidatus Nitrospira defluvii" 
rabbit as indicated (71) 
 
2.6.2 Secondary antibodies 
Secondary antibodies were purchased from Dianova (Hamburg, Germany) and GE 
Healthcare Bio-Sciences AB (Uppsala, Sweden). 
 
Secondary antibodies used carried one of the following modifications: 
- The fluorophor Indocarbocyanine (Cy3) 
- The fluorophor Carbocyanine (Cy2) 
- The fluorophor Indodicarbocyanine (Cy5) 
- The fluorophor Fluorescein (FITC) 
- The enzyme Horseraddish-Peroxidase (HRP) 
 
Table 10: Secondary antibodies used in this study 
Antibody Antigen Modification Source of 
antibody 
Dilution Manufacturer 
anti-chicken chicken IgY Cy3 donkey 1:1,000 Dianova 
anti-chicken chicken IgY Cy2 donkey 1:1,000 Dianova 
anti-chicken chicken IgY Cy5 donkey 1:1,000 Dianova 
anti-chicken chicken IgY HRP goat 1:10,000 Dianova 
anti-guinea pig guinea pig IgG Cy3 goat 1:1,000 Dianova 
anti-guinea pig guinea pig IgG Cy2 goat 1:1,000 Dianova 
anti-guinea pig guinea pig IgG Cy5 goat 1:1,000 Dianova 
anti-guinea pig guinea pig IgG HRP goat 1:10,000 Dianova 
anti-rabbit rabbit IgG Cy3 goat 1:1,000 Dianova 
anti-rabbit rabbit IgG Cy2 goat 1:1,000 GE Healthcare 
Bio-Sciences AB 
anti-rabbit rabbit IgG FITC goat 1:1,000 Dianova 
anti-rabbit rabbit IgG Cy5 goat 1:1000 Dianova 
anti-rabbit rabbit IgG HRP goat 1:10,000 Dianova 
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2.7 Primers 
Primers were produced by Thermo Fisher Scientific GmbH  (Ulm, Germany). 
 
Table 11: Primers used for the amplification of 16SrRNA gene fragments 
Primer 
name 
Primer sequence* 
(5´-3´) 
Size of 
amplified 
fragment 
Specificity Annealing 
temperature 
Reference 
 
PcR 
GTC ATC RGC 
CYY ACC TTV SRC 
RYY TCT 
 
 
1,260 bp 
 
 
Parachlamydiaceae, 
Waddliaceae 
 
 
 
58°C 
 
 
(53) 
PcF TCA GAT TGA 
ATG CTG AC 
PanF CGTGGATGAGGC
ATGCRAGTCG 
 
 
1,445 bp 
 
 
Chlamydiales 
 
 
 
65°C 
 
 
(22)  
PanR 
GTC ATC RGC 
CYY ACC TTV SRC 
RYY TCT 
1492R GGY TAC CTT GTT 
ACG ACT T 
 
 
1,480 bp 
 
 
Bacteria, but not 
Chlamydiales 
 
 
52°C 
 
 
(67) 
616 V AGA GTT TGA 
TYM TGGC 
 * According to the NC-IUB the unspecified bases are represented as follows: R = G or A, Y = T or C, M = 
A or C, V = G or C or A, S = G or C, N = G or C or A or T; 
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2.8 Media and buffers 
Media and buffers described here were sterilized for 20 min at 121°C and 1,013 x 10
5
 Pa 
pressure in a watervapour-high pressure autoclave if not stated otherwise. Buffers 
containing ethanol or isopropanol were not autoclaved or were autoclaved before the 
addition of these components.  If not indicated otherwise, media and buffers were stored 
at room temperature (RT) until further use. 
If indicated in the text, buffers were filter-sterilized by passing them through a 0.2 µm 
filter. 
 
2.8.1 Media for cultivation of organisms 
 
2.8.1.1 Medium for axenic cultivation of amoebae 
 
Trypticase Soy Broth with Yeast Extract (TSY) 
Trypticase Soy Broth  30 g 
Yeast extract 10 g 
H2Odd ad 1000 ml 
pH 7.3 
 
PYG 
Peptone 20 g 
Glucose 18 g 
Yeast extract 2 g 
Sodiumcitrate 1 g 
MgSO4 x 7 H2O 980 mg 
Na2HPO4 x 7 H2O 355 mg 
KH2PO4 340 mg 
Fe(NH4)2(SO4)2 x 6 H2O 20 mg 
H2Odd ad 1000 ml 
pH 6.5 
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2.8.1.2 Medium for cultivation of E. coli 
 
Luria Bertani medium (LB medium) 
Tryptone  10 g 
Yeast extract  5 g 
NaCl  5 g 
H2Odd  ad1000 ml 
pH 7.0 - 7.5 
For solid media 15 g/l agar were added to the medium before autoclaving. 
 
Antibiotics 
Ampicillin stock solution (Amp)  100 mg/ml 
  
Amp was dissolved in 50 % EtOHabs and stored at -20°C until further use. 
Amp was added to medium to reach a final concentration of 100 μg/ml. 
 
2.8.2 General buffers 
 
10 x Page’s Amoebic Saline (PAS) 
NaCl 1.20 g 
MgSO4 x 7H20 0.04 g 
CaCl2 x H20 0.04 g 
NaH2PO4 x 2H20 1.78 g 
KH2PO4 1.36 g 
H2Odd ad 1000 ml 
 
1 x PAS 
10 x PAS 100 ml 
H2Odd ad 1000 ml 
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PBS stock solution 
Solution 1:  35.6 g/l Na2HPO4   
Solution 2: 27.6 g/l NaH2PO4  
pH of solution 1 was adjusted to 7.2-7.4 by adding solution 2 
 
1 x PBS 
PBS stock solution 50 ml 
NaCl 7.6 g 
H2Odd ad 1000 ml 
 
SPG-buffer 
Sucrose 75 g    
KH2PO4   0.52 g    
Na2HPO4 x 2 H20 2.30 g 
Glutamc acid 0.75 g 
H2Odd ad l000 ml 
 
2.8.3 Buffers, solutions and standards for gel electrophoresis 
 
Buffers and solutions for gel electrophoresis were not autoclaved. 
 
10 x TBE 
Tris-HCl 162.0 g 
Boric acid 27.5 g 
EDTA 9.3 g 
H2Odd ad 1000 ml 
pH 8.3 – 8.7 
 
1 x TBE 
10 x TBE 100 ml 
H2Odd ad 1000 ml 
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Loading buffer 
Ficoll 25 % (w/v) 
Bromphenol blue 0.5 % (w/v) 
Xylencyanol 0.5 % (w/v) 
EDTA 50 mM 
H2Odd 
 
Ethidium bromide solution 
Ethidium bromide stock solution: 
10 mg/ml Ethidium bromide (EtBr) in H2Odd 
 
Ethidium bromide staining solution: 
Ethidium bromide stock solution diluted 1: 10,000 in H2Odd 
 
DNA ladders  
GeneRuler
TM
 1kb (Fermentas Inc., Hanover, MD, USA) 
GeneRuler™ 100 bp (Fermentas Inc., Hanover, MD, USA) 
 
2.8.4 Buffers, solutions and standards for Sodium dodecyl sulfate 
polyacrylamide gel electrophoresis (SDS – PAGE) 
 
Buffers and solutions for SDS-PAGE were not autoclaved, except for lower and upper 
buffer. 
 
Lower buffer 
Tris–HCl  90.8 g 
10% (w/v) Sodium dodecyl Sulfat (SDS) 20 ml  
H2Odd ad 500 ml 
pH 8.8 
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Upper buffer 
Tris-HCl  30.3 g  
10 (w/w)% SDS  20 ml 
H2Odd  ad 500 ml 
pH 6.8 
 
10 x SDS-PAGE running buffer 
Tris-HCl 30.2 g 
Glycine  144 g 
SDS 10 g 
 H2Odd  ad 1000 ml 
 
4 x SDS - PAGE loading buffer  
Tris-HCl pH 6.8 2.42 g 
SDS 8 g 
Bromphenolblue 0.02 g 
Glycerol 40 µl 
Dithiothreitol (DTT)  6.2 g 
H2Odd  ad 100 ml 
 
Coomassie brilliant blue staining solution  
Methanol 50 % (v/v) 
Acetic acid 10 % (v/v) 
Brilliant Blue G-250 2.76 g 
H2Odd ad 1000 ml 
 
Destaining solution  
Acetic acid 5 % (v/v) 
Ethanol  20 % (v/v) 
H2Odd ad 1000 ml 
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Colloidal Coomassie solution 
(NH4)2SO4 100 g 
Orthophosphoric acid 20 g 
Methanol 25 % (v/v) 
Coomassie Brilliant Blue G-250 0.625 g 
H2Odd ad 1000 ml 
 
Fixing solution  
Ethanol 40 % (v/v) 
Acetic acid 10 % (v/v) 
H2Odd ad 2000 ml 
 
Protein Ladders 
Unstained Protein Molecular Weight Marker (Fermentas Inc., Hanover, MD, USA) 
PageRuler™ Prestained Protein Ladder (Fermentas Inc., Hanover, MD, USA) 
 
2.8.5 Buffers and solutions for Western Blot analysis 
 
Buffers and solutions for Western Blot analysis were not autoclaved, except for 10 x 
TBS. 
 
Transfer buffer 
Glycine  14.4 g  
Tris-HCl  3 g  
Methanol 20 % (v/v) 
H2Odd ad 1000 ml 
 
10 x TBS 
Tris-HCl  12.1 g 
NaCl 43.8 g 
H2Odd  ad 500 ml 
pH 7.5; store at  4°C 
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1 x TBS 
10 x TBS 100 ml 
H2Odd ad 1000 ml 
store at 4°C 
 
TBS-T 
10 x TBS 50 ml 
Tween 20  0.1% (v/v)  
H2Odd ad 500 ml 
store at  4°C 
 
Developer and Fixer solution 
SIGMA Kodak GBX Developer  
SIGMA Kodak GBX Fixer 
Developer and Fixer were diluted as recommended by the manufacturer 
 
2.8.6 Buffers for purification of pc1489 
 
Buffer A 
HEPES pH 7.5 2.9 g 
NaCl 0.292 g 
n-octyl–Polyoxyethylen (n-octyl-POE) 0.25 g 
H2Odd  ad 500 ml 
 
Buffer B 
HEPES pH 7.5 0.29 g 
NaCl 5.84 g 
n-octyl–POE 0.025 g 
H2Odd  ad 50 ml 
 
300 mM NaxPO4 
Solution 1:  53.4 g/l Na2HPO4   
Solution 2: 41.4 g/l NaH2PO4  
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pH of solution 1 was adjusted to 6.5 by adding solution 2 
 
3 x PEN 
EDTA 0.087 g 
NaCl 5.84 g 
300 mM NaxPO4  ad 1000 ml 
 
POP 05 – buffer 
n-octyl–POE 0.5% (w/v) 
3 x PEN ad 50 ml 
 
2.8.7 Buffers and solutions for antibody preparation and immunofluorescence 
 
Binding Buffer 
NaH2PO4  3.12 g 
K2SO4   87.13 g 
H2Odd  ad 1000 ml 
pH 7.5  
 
Elution Buffer 
NaH2PO4  3.12 g 
H2Odd  ad 1000 ml 
pH 7.5  
 
Cleaning Buffer 
NaH2PO4  3.12 g 
Isopropanol  30% (v/v) 
H2Odd  ad 1000 ml 
pH 7.5  
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10 x PBS 
Na2HPO4    26.8 g 
NaH2PO4    13.8 g 
NaCl 81.6 g 
H2Odd  ad 1000 ml 
 
4 % PFA 
1 x PBS 25 ml 
Paraformaldehyde (37% w/v) 2.7 ml 
 
FA-Block solution 
Bovine Serum Albumine (BSA)  20 g 
10 x PBS 100 ml 
H2Odd  ad 1000 ml 
 
50 ml aliquots of FA-Block solution were stored at -20°C until further use. Upon 
thawing, FA-Block solution was stored at 4°C up to 2 weeks. 
 
Mowiol 
4 g Mowiol were mixed with 6 g glycerine and 6 ml H2Odd. 12 ml 0.2 M Tris-HCl 
solution (pH 8.5) was added and the solution was stirred at 50°C overnight. When the 
Mowiol had dissolved completely, the solution was centrifuged at 7,700 x g for 15 
minutes (min) to remove air bubbles. The supernatant was collected and stored in aliquots 
at -20°C until further use. 
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2.9 Cell culture 
  
2.9.1 Cultivation of Acanthamoeba castellanii Neff 
 
Solutions 
TSY medium  
PYG medium  
 
Procedure 
Acanthamoeba castellanii Neff and Acanthamoeba sp. UWC1 isolates containing either 
no endosymbiont or harbouring endosymbionts were grown axenically in small or large 
culture flasks in 10 ml or 150 ml TSY or PYG medium. Cultures were grown at a 
constant temperature of 20°C in an incubator and were checked for contaminations with 
extracellular bacteria or fungi using an inverse microscope at regular intervals.  
Medium was exchanged every one or two weeks, depending on the growth of amoebae, 
by pouring out the old medium in a glass bottle and adding new, fresh medium to the 
flasks. 
 
2.9.2 Harvesting of amoebae 
Amoeba cultures were harvested by shaking the culture flasks vigorously to detach 
amoebae from the bottom of the flask. The supernatant of the culture containing detached 
amoebae was collected in 50 ml Greiner tubes. Cell pellets were obtained by 
centrifugation at 7,323 x g for 5 min. TSY or PYG medium was added to the culture 
flasks to enable growth of remaining amoebae.  
 
2.9.3 Cultivation of E. coli 
 
Solutions 
LB medium  
Ampicillin stock solution  
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Procedure 
E. coli cells were grown on LB plates or in liquid LB medium at 37°C. For culturing cells 
in liquid media, 5 ml of LB medium were inoculated with a single colony from a plate or 
cells from a glycerol stock under sterile conditions and incubated on an orbital shaker at 
200 rpm. Recombinant E. coli cells harbouring a plasmid were grown in the presence of 
100 µg/ml ampicillin to avoid the growth of cells without plasmid. 
LB plates with E. coli colonies were stored at 4° for several weeks. 
 
2. 10 General methods 
 
2.10.1 Amplification of DNA fragments via Polymerase Chain Reaction (PCR)  
 
Solutions 
MgCl2 (25 mM) (Fermentas Inc. Hanover, MD, USA) 
Nucleotide Mix (2.5 mM each dNTP) 
10 x Ex Taq polymerase buffer 
Taq DNA Polymerase (5U/µl)  
Forward primer (50 pmol/µl) 
Reverse primer (50 pmol/µl) 
Aquabidest. (Mayrhofer Pharmazeutika GmbH & Co KG, Leonding, Austria) 
 
 
Procedure  
To avoid contaminations by external DNA, Aquabidest., MgCl2, 10 x Ex Taq polymerase 
buffer and tubes used for PCR were exposed to ultra-violet (UV) light in a UV sterilizing 
PCR hood for 20 min before preparing the standard reaction mixture. All pipetting steps, 
except for the addition of the positive control, were carried out under the PCR hood. 
For amplification of DNA fragments via PCR, the following standard reaction mixture 
was prepared: 
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Standard reaction mixture 
MgCl2  4 µl 
10 x Taq buffer Buffer 5 µl 
dNTP – Mix 5 µl 
Forward primer (50 pmol/µl) 1 µl 
Reverse primer (50 pmol/µl) 1 µl 
Template 100 ng 
Aquabidest. ad 50 µl 
 
For each PCR, a positive and a negative control were included. 
For the amplification of 16S rRNA gene fragments, PCR was performed at the following 
conditions: 
 
PCR step Temp. [°C] Time 
Number of 
cycles 
Denaturation 95 90 sec 1 
Denaturation 95 30 sec  
Annealing * 30 sec 35 
Elongation 72 90 sec  
Final 
elongation 72 420 sec 1 
* for annealing temperatures, see Table 11 
 
Obtained PCR products were analyzed quantitatively by photometric analysis and 
qualitatively by agarose gel electrophoresis. 
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2.10.2 Quantitative and qualitative analysis of nucleic acids 
 
2.10.2.1 Quantitative, photometric analysis of nucleic acids 
Concentration of nucleic acids was measured with a NanoDrop® ND-1000 
spectralphotometer. 1.5 µl of nucleic acid solution was pipetted onto the end of the fibre 
optic cable of the NanoDrop® device. Measurements were performed at λ = 260 nm 
according to the instructions of the manufacturer. 
 
2.10.2.2 Qualitative analysis of nucleic acids by agarose gel electrophoresis 
 
Solutions 
1 x TBE  
Loading buffer  
DNA ladder  
EtBr staining solution  
 
Procedure 
Nucleic acid samples were analysed on agarose gels with concentrations of 1-2.5 % 
agarose (1.5 g–3.75 g agarose in 150 ml 1 x TBE). Samples were mixed with 1 volume of 
loading buffer and pipetted into the pockets of the gel. Nucleic acids were separated by 
applying a voltage of 80 – 100 V for 60 - 90 min, depending on type of analysis. 
Separated nucleic acids were stained with EtBr staining solution for 30 min and 
visualized with a transilluminator emitting UV- light (λ = 312 nm). Band patterns were 
recorded and digitalised using a gel–documentation system (Biostep, Jahnsdorf, 
Germany). 
 
2.10.3 Sequencing of PCR products 
Certain PCR products were sequenced by Mag. Christian Baranyi using an ABI 3130xl 
DNA sequencer and the BigDye Terminator Cycle Sequencing Kit v3.1 (Applied 
Biosystems), which is based on Sanger‟s chain-termination method for sequencing. 
Brieflly, incorporation of  ddNTPs linked to different fluorescent dyes into a newly 
synthezised DNA-strand results in termination of elongation. DNA-fragments of different 
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sizes are separated electrophoretically and recognized by a laser and the resulting 
chromatograph representing the DNA sequence is recorded. 
For sequencing, the same primers as for PCR analysis were used at a concentration of 10 
pmol/µl. Sequences were proof-read manually using the FinchTV software (Geospiza) 
and subjected to BLAST search using the general nucleotide collection database 
(http://blast.ncbi.nlm.nih.gov/Blast.cgi) to find the most similar sequence (2). 
 
2.10.4 Analysis of proteins by Sodium dodecyl sulfate polyacrylamide gel 
electrophoresis (SDS-PAGE) 
 
2.10.4.1 Sample preparation for SDS-PAGE analysis 
 
2.10.4.1.1 Sample preparation from cell cultures 
Cell pellets were obtained by centrifugation at 17,949 x g for 2 min for E. coli or 
harvesting of amoebae at 7,323 x g for 5 min. Cells were resuspended in 1 x PBS and 
centrifuged as before. The obtained pellet was resuspended in 50-60 µl 4 x SDS-PAGE 
loading buffer, depending on the size of the pellet. Samples were heated to 95°C for 5 
min to break the cells and cooled down again. 
Nucleic acids present in the samples were removed by digestion with the nuclease 
Benzonase. 1 µl of Benzonase was added to the samples and digestion was performed for 
1 hour at 4 °C. Samples were stored at -20°C until further use. Before loading on the gel, 
samples were heated to 95°C for 5 min. 
 
2.10.4.1.2 Sample preparation for purified proteins 
4 x SDS - PAGE loading buffer without DTT was added to the samples and samples were 
applied to the gel without heating.  
 
2.10.4.2 SDS-PAGE-analysis 
 
Solutions 
Lower buffer  
Upper buffer  
Rotiphorese
®
NF-30% (w/v) Acrylamide/Bisacrylamide-solution  
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10% (w/v) Ammonium persulfate (APS)       
N,N,N´,N´-tetramethylethane-1,2-diamine (TEMED) 
1 x SDS-PAGE running buffer  
Protein Ladder  
 
Procedure 
Separating and stacking gel were prepared according to the following standard reaction 
mixtures: 
 
Separating gel 
Lower buffer 2 ml 
H2Odd 2.66 ml 
Acrylamide/Bisacrylamide solution 3.33 ml 
APS 40 µl 
TEMED 8 µl 
 
Stacking gel 
Upper buffer 0.63 ml 
H2Odd 1.63 ml 
Acrylamide/Bisacrylamide solution 0.38 ml 
APS 17.5 µl 
TEMED 10 µl 
 
12.5% polyacrylamide gels were prepared by use of a Mini-PROTEAN casting stand. 
Lower buffer, H2Odd and acrylamide/bisacrylamide solution were mixed and APS and 
TEMED were added to initiate polymerization of the gel. The separating gel solution was 
poured between the two glass plates of one cassette and gels were overlaid with 
isopropanol to produce a smooth surface of the separating gel. After polymerization of the 
separating gel, the isopropanol was poured off. The stacking gel was prepared by mixing 
upper buffer, H2Odd and acrylamide/bisacrylamide solution and adding APS and TEMED. 
A layer of stacking gel was added on top of the separating gel and combs were applied. 
Polymerized gels were wrapped in wet paper towels and saran wrap and stored at 4°C for 
a few days until further use. 
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For separation of proteins, gels were inserted into a Mini PROTEAN gel electrophoresis 
chamber and the chamber was filled with 1 x SDS-PAGE running buffer. Samples and 
marker were pipetted into the pockets of the gel. Proteins were separated by applying a 
voltage of 60 – 110 V for 1.5 hours, depending on type of analysis. The run was stopped 
when the marker front reached the bottom of the gel. The gel apparature was dissembled 
and gels were stained as described below. 
 
2.10.4.3 Staining and destaining of SDS-PAGE-gels using Coomassie brilliant blue 
staining solution  
 
Solutions 
Coomassie brilliant blue staining solution  
Destaining solution  
 
Procedure 
After electrophoresis, gels were stained in Coomassie brilliant blue staining solution on a 
rocking platform for 45 min followed by destaining in Destaining solution overnight. 
Gels were rinsed with H2Odd and digitalised by scanning. 
 
2.10.4.4 Fixation, staining and destaining of SDS-PAGE-gels using colloidal 
Coomassie staining solution 
 
Solutions 
Colloidal Coomassie solution  
Fixing solution  
 
Procedure 
After electrophoresis, gels were rinsed for 5 min with H2Odd, followed by incubation for 
20 min in fixing solution. Gels were rinsed 2 times for 10 minutes in H2Odd and stained 
with colloidal Coomassie overnight. On the following day, gels were destained by rinsing 
them 2 times for 30 min in H2Odd. All these steps were carried out on a rocking platform. 
After destaining, gels were digitalised by scanning.  
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2.10.5 Western blot analysis 
 
Solutions 
Transfer buffer  
1 x TBS  
TBS-T  
Developer and Fixer solution  
 
Procedure 
Proteins were separated by SDS-PAGE as described in 2.10.4. The gel electrophoresis 
chamber was dissembled and the stacking gel was removed from the resolving gel. The 
resolving gel was equilibrated for 15 min in transfer buffer. A polyvinylidene fluoride 
(PVDF) membrane and 6 pieces of Whatman paper were cut to the size of the separating 
gel. The PVDF membrane was activated by shaking in methanol for 5 min, followed by 
rinsing with H2Odd for 5 min. Transfer onto the membrane was performed by semi-dry 
blotting in a TE77 semi-dry transfer unit filled with transfer buffer for 1.5 hours at 
settings as recommended by the manufacturer.  
Non-specific binding of proteins was prevented by incubating the membrane in 5% non-
fat dry milk in 1 x TBS on a rocking platform overnight.  Blocking of the membrane was 
followed by incubation in 10 ml TBS-T with the primary antibody against the respective 
protein for 1 hour. The membrane was washed 3 times in TBS-T for 15 min to remove 
excess primary antibody, followed by incubation in TBS-T with the corresponding HRP-
labelled secondary antibody for 1 hour. After 3 additional washing steps, the signal was 
detected by using the Western Lightning Chemiluminescence Plus Kit as recommended 
by the manufacturer. The membrane was exposed to a photographic film in the dark. The 
film was developed with Developer Solution, fixed with Fixer Solution and washed in 
H2O. Films were digitalised by scanning. 
 
2.11 Purification of P. amoebophila EBs 
For purification of the putative porin pc1489 and for infection studies, EBs were purified 
from Acanthamoeba castellanii cultures infected with P. amoebophila. Amoebae were 
broken up in a procedure that also destroyed RBs present in the sample. The cell debris 
was removed by filtration and centrifugation, yielding purified EBs.  
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2.11.1 Partial purification of P. amoebophila EBs 
 
Solutions 
1 x PAS  
SPG-buffer  
 
Procedure 
12 – 15 large cultures of A. castellanii cultures infected with P. amoebophila were 
harvested (sec. 2.9.2). The pellet was washed in 1 x PAS, centrifuged (7,323 x g, 5 min) 
and the resulting pellet was resuspended in 1 x PAS. 4 freeze-and-thaw steps (freezing at 
-20°C/ thawing at 42°C in a water bath) were performed to disrupt amoeba cell 
membranes, followed by shearing of the samples with an equal volume of glass beads for 
3 minutes. To remove glass beads and cell debris, the lysate was centrifuged for 10 min at 
300 x g and 4°C. The resulting supernatant was filtered through a 1.2 µm filter and 
transferred to an ultracentrifuge tube. The cell suspension was filled up to 10 ml with 
precooled SPG-buffer and centrifuged at 40,000 x g for 40 min a 4°C in an 
ultracentrifuge. The resulting pellet was resuspended in 10 ml precooled SPG-buffer and 
centrifuged as before. The pellet was resuspended in 6 ml SPG–buffer and passed through 
a 0.45 µm syringe to singularize EBs. The resulting suspension was aliquoted to screw 
caps. To ensure that purified EBs were not contaminated with other bacteria or fungi, 1 
ml of TSY was inoculated with 10 µl of each screw cap and incubated for 5 days at 20°C. 
Samples were checked for growth of bacteria or fungi with an inverse microscope.  The 
remaining EB-suspension was stored at -80°C until further use. 
 
2.11.2 High purification of P. amoebophila EBs 
High purification of P. amoebophila involved two additional gradient centrifugation steps 
compared to partial purification. During gradient centrifugation, EBs formed a pellet at 
the bottom of the tube, whereas amoeba cell debris accumulated at the interface between 
gastrografin and sucrose. 
 
Solutions 
1 x PAS  
SPG-buffer  
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30 mM Tris-HCl buffer (pH 7.3) 
30% (v/v) Gastrografin in H2Odd 
50% (w/v) sucrose in H2Odd 
 
Procedure 
12 – 15 large cultures of A. castellanii infected with P. amoebophila were harvested, 
washed in 1 x PAS and the resulting pellet was resuspended in 3 ml 30 mM Tris-HCl 
buffer. Amoeba cells were disrupted as described above (2.11.1). To remove glass beads 
and amoeba cell debris, the lysate was centrifuged for 10 min at 4°C and 300 x g. The 
resulting supernatant was filtered through a 1.2 µm filter and transferred to a clean 
ultracentrifuge tube. The cell suspension was filled up to 10 ml with 30 mM Tris-HCl 
buffer and centrifuged at 40,000 x g for 1 h at 4°C in an ultracentrifuge. The resulting 
pellet was resuspended in 1 ml precooled SPG-buffer. For further purification, a sucrose-
gastrografin-gradient was prepared by overlaying 3 ml 50 % sucrose with 3 ml 30 % 
gastrografin and overlaying the gastrografin with 3 ml sample. Gradient centrifugation 
was performed at 40,000 x g for 2 h at 4°C two times. Between centrifugation steps, the 
cell suspension was passed through a 0.45 µm syringe in order to singularize bacteria. 
The pellet of the last centrifugation step was resuspended in 6 ml SPG-buffer and passed 
again through a 0.45 µm syringe. The resulting suspension was aliquoted to screw caps 
and screened for the presence of other bacteria or fungi as described in 2.11.1. Aliquots 
were stored at -80°C until further use. 
 
2.12 Screening of amoeba cultures 
 
To ensure that Acanthamoeba castellanii cultures were not contaminated with 
extracellular bacteria or other chlamydiae, cultures were screened at regular intervals and 
each time before purification of EBs was performed.  
 
2.12.1 DAPI staining of amoebae 
Every 2-3 weeks and before purification of EBs was started, cultures were screened by 
staining with 4',6-Diamidino-2-phenylindol  (DAPI).  
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Solutions 
DAPI  
1 x PAS  
4% PFA in 1 x PBS  
 
Procedure 
DAPI was prepared at a dilution of 1:10,000 and stored at 4°C until further use. 
1 ml of an amoeba culture was harvested by centrifugation at 5,974 x g for 5 min. The 
resulting pellet was resuspended in 1 x PAS and centrifuged as before.  The pellet was 
resuspended in 200 µl 1 x PAS. 20 µl of this suspension were applied to the well of a 
microscope slide. Amoebae were allowed to attach for 30 min. Then, the liquid was 
removed carefully and 10 µl of 4 % PFA were added instead to fix cells. After incubation 
for 10 min at RT, the fixative was removed and wells were washed with 10 µl H20dd. 10 
µl of the DAPI solution were added onto each well and slides were incubated for 7 min in 
the dark. The DAPI-solution was removed and wells were washed with 20 µl H20dd. 
Slides were dried at RT in the dark, followed by embedding in Citifluor. Fluorescently 
labelled cells were analyzed by epifluorescence microscopy.  
 
2.12.2 Screening of cultures via PCR 
If investigation by light microscopy or staining with DAPI indicated the presence of 
contaminations with extracellular bacteria or other endosymbionts in amoeba cultures, 
DNA was isolated from these cultures and 16S rRNA gene-fragments were amplified by 
PCR followed by sequencing and BLAST search. 
 
Procedure 
10 ml of an amoeba culture were harvested and DNA was isolated from the resulting 
pellet using the DNeasy Blood & Tissue Kit according to instructions of the manufacturer 
and using the protocol for Gram-negative bacteria. DNA-concentrations were measured 
with a NanoDrop® ND-1000 spectralphotometer and 100 ng of DNAwere used as 
template for PCR. 
To amplify 16S rRNA genes of bacteria, the primer pair 616V and 1492R was used. 
Primers PcF and PcR were used to amplify chlamydial 16S rRNA genes as described 
above (sec. 2.10.1). Resulting PCR products were checked quantitatively and 
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qualitatively (sec. 2.10.2), purified using the Qiaquick PCR purification Kit according to 
the manufacturer‟s instructions and subjected to sequencing (sec. 2.10.3). 
 
2.12.3 Screening of cultures for bacteria present in low amounts  
The primers 616V and 1492R do not only target 16S rRNA genes of bacteria, but also 
16S rRNA genes of mitochondria. Mitochondria are present in high amounts in amoebae. 
Thus, bacteria that are present in low amounts were not detected by the approach 
described in 2.12.2. To detect these bacteria, samples were enriched before PCR analysis. 
 
Solutions 
1 x PAS (filter-sterilized)  
TSY  
 
Procedure 
To detect extracellular bacteria present in low amounts, amoeba cultures were harvested 
and resuspended in 3 ml 1 x PAS (filter-sterilized). Amoebae were removed by passing 
samples through a 5 µm filter. The resulting suspension was used to inoculate 10 ml of 
TSY medium. TSY tubes were incubated for 7 days at RT to allow growth of bacteria. 
Samples were centrifuged at 5,974 x g for 5 min and resuspended in 50 µl 1 x PAS. 5 µl 
of this solution were subjected to DAPI-staining (2.12.1). The remaining solution was 
used to isolate DNA for PCR analysis using the DNeasy Blood & Tissue Kit according to 
instructions of the manufacturer and using the protocol for Gram-negative bacteria. 100 
ng of DNA were used as template for PCR. Bacterial 16S rRNA gene-fragments were 
amplified using the primer pair 616V and 1492R as described in 2.10.1. 
Resulting PCR products were checked quantitatively and qualitatively (2.10.2). PCR 
products were purified using the Qiaquick PCR purification Kit according to the 
manufacturer‟s instructions and subjected to sequencing (2.10.3). 
 
2.12.4 Screening of purified P. amoebophila EBs by PCR and RFLP analysis 
After partial and high purification, 16S rRNA genes of the resulting EBs were analysed 
by Restriction Fragment Length Polymorphism (RFLP) analysis with the restriction 
enzyme VspI. This restriction enzyme recognizes the sequence 5'-ATTAAT-3'. This 
sequence is present once in the 16S rRNA sequence of P. amoebophila, but twice in 
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Parachlamydia sp., thereby allowing differentiation of different environmental 
chlamydiae by RFLP analysis. 
 
Procedure 
Purified EBs of P. amoebophila were thawed at 37°C and centrifuged at 17,949 x g for 30 
min at 4°C. From the resulting pellet, DNA was purified using the DNeasy Blood & 
Tissue Kit according to instructions of the manufacturer using the protocol for Gram-
negative bacteria. The DNA-concentration was measured using a NanoDrop® ND-1000 
spectralphotometer and 100 ng of DNA were used as a template for the following PCR. 
PCR was performed as described in 2.10.1 using the primer pair PanF and PanR. 
Resulting PCR products were digested using the restriction enzyme VspI according to the 
following standard reaction mixture: 
 
Standard reaction mixture 
PCR-product  5 µl 
Buffer O  1 µl 
VspI   0.2 µl 
H20dd  3.8 µl 
 
The reaction mixture was incubated for 3 hours at 37°C. Digestion was stopped by 
addition of 5 µl loading dye. Samples were analysed by agarose gel electrophoresis as 
described in 2.10.2.2. 
 
2.13 Purification of the putative porin pc1489 from highly-purified 
elementary bodies 
The putative porin pc1489 was purified from elementary bodies to get amounts sufficient 
for immunization of one chicken and for performing lipid bilayer measurements.  
EBs were incubated with detergent and the reducing agent DTT to solubilize membrane 
proteins. Obtained proteins were resuspended in a buffer with pH 7.5. Proteins were 
loaded on an anionic-exchange column and eluted from this column by applying a NaCl-
concentration-gradient to the column. Pc1489 is predicted to have an isoelectric point of 
6.75 in the environmental chlamydia genome database 
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(http://mips.gsf.de/genre/proj/uwe25/). At pH 7.5, pc1489 should be negatively charged 
and therefore be able to bind to the anionic exchange column.  
 
Solutions 
Buffer A 
Buffer A without n-POE 
Buffer B  
3 x PEN  
POP05–buffer with 100 mM DTT  
4 x SDS - PAGE loading buffer without DTT  
 
Procedure 
Highly purified EBs were thawed, transferred to new 1.5 ml tubes and pelleted by 
centrifugation at 10,621 x g for 15 min at 4°C. The pellet was resuspended in 100 µl 
POP05-buffer with 100 mM DTT/3 mg EB (wet weight) and incubated for 1 hour at 37°C 
on a rocking platform. After this, cell debris was removed by centrifugation (10,621 x g, 
10 min, 4°C) and the resulting supernatant containing solubilized membrane proteins was 
transferred into a 1.5 ml tube. A sample of 5 µl was withdrawn for SDS-PAGE analysis. 
An equal volume of ice-cold acetone was added to the supernatant and proteins were 
precipitated for 1 hour at -20°C. After 1 hour, the suspension was centrifuged as before 
and the resulting pellet was resuspended in 400 µl Buffer A. After incubation for 10 min 
at room temperature, the suspension was centrifuged at 10,621 x g for 10 min at 20°C to 
remove undissolved matter. 12 µl of the supernatant were withdrawn for SDS-PAGE 
analysis. A Vivapure Q-Mini-spin column was equilibrated by applying 400 µl Buffer A 
on top of the membrane and centrifugation at 2,000 x g for 5 min. The flow-through was 
discarded. The supernatant was loaded onto the Vivapure Q-Mini-spin column. Proteins 
were bound to the membrane of the column by centrifugation at 2,000 x g for 5 min and 
the flow-trough was collected. The column was washed 2 times with Buffer A and the 
flow through was collected. Elution of proteins was achieved by applying mixtures of 
Buffer A and Buffer B with increasing NaCl concentrations to the membrane, starting 
with the lowest concentration, and centrifugation at 2,000 x g for 5 min at 20°C. NaCl-
concentrations used for protein elution are listed in Table 12. The flow-through of all 
elution-steps was collected. 12 µl of each fraction and 3 µl of the supernatant after 
incubation at 37°C were used for SDS-PAGE analysis. 5 µl of 4 x SDS - PAGE loading 
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buffer without DTT was added to each sample and samples were run on a SDS-PAGE-
gel, followed by staining with colloidal Coomassie (sec. 2.10.4). Fractions that seemed to 
contain only a single band for pc1489 at the correct size  
after SDS-PAGE analysis were 
collected and pooled. Protein 
concentrations of these fractions were 
determined using the BCA
TM
 Protein 
Assay Kit (2.14). 
To increase protein concentrations, 
another precipitation step was 
performed by adding 4 volumes of ice-
cold acetone to 1 volume of sample. 
Proteins were precipitated overnight at -
20°C. The sample was centrifuged at 
10,621 x g for 30 min at 4°C and the 
pellet was resuspended in the amount of 
Buffer A without n-POE necessary to 
obtain a protein concentration of 1 
mg/ml. The purity of the precipitated proteins was checked by SDS-PAGE analysis 
(2.10.4). 
 
2.14 Determination of protein concentrations with the BCA
TM
 Protein 
Assay Kit 
Protein concentrations were measured using the BCA
TM
 Protein Assay Kit.  
All samples and standards were prepared and measured as suggested by the manufacturer 
for the Enhanced Protocol.  
All measurements were performed in duplicates and the mean absorbance of these 
duplicates was used for the determination of protein concentrations.  
 
Table 12: Volumes of Buffer A and B mixed to     
obtain the required concentration of NaCl for 
elution of pc1489. 
NaCl-
concentration 
Buffer A Buffer B 
100 mM NaCl 955 µl 45µl 
250 mM NaCl 879 µl 121µl 
300 mM NaCl 854µl 146µl 
350 mM NaCl 829µl 171µl 
400 mM NaCl 804µl 196µl 
550 mM NaCl 729µl 271µl 
700 mM NaCl 653µl 347µl 
850 mM NaCl 578µl 422µl 
1000 mM NaCl 503µl 497µl 
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2.15 Mass spectrometry analysis 
To identify proteins that were present in gel bands after purification of pc1489, bands of 
interest were excised from the gel. Proteins were digested with Trypsin and analysed by 
linear trap quadruple – mass spectrometry.  
2.15.1 Sample preparation for mass spectrometry 
 
Solutions 
10% (v/v) and 0.1% (v/v) trifluoroacetic acid (TFA) 
50 mM ammonium bicarbonate (ABC-buffer) 
Acetonitrile (ACN) 
Alkylation buffer (10 mg/ml iodacetamide in 50 mM ABC) 
Destaining solution (100 µl 50 mM ABC + 80 µl ACN (44% (v/v)) 
Reduction buffer (10 mM DTT in 50 mM ABC) 
Trypsin gold working solution: 
Trypsin gold was added to 50 mM acetic acid to yield a concentration of 100 ng/µl and 
aliquots were stored at -80°C. Immediately before use, 10 µl were thawed and diluted by 
addition of 70 µl ABC-buffer, resulting in a final concentration of 12.5 ng/µl 
 
Procedure 
Band of interest stained with colloidal Coomassie were excised from gels after SDS-
PAGE and were transferred to screw caps and stored at -80°C for further use or 
immediately processed for analysis by mass spectrometry. Gel bands were washed three 
times in 200 µl H20dd, followed by destaining of spots by adding 100 µl destaining 
solution. The solution was replaced every 15 min, until the gel bands were completely 
destained. This was followed by incubation for 5 min in acetonitrile. All these steps were 
carried out on a rocking platform at 20°C. ACN was removed and bands were vacuum-
dried for 5 minutes at RT. 
Samples were reduced in 200 µl reduction buffer for 30 min at 56°C, followed by 
incubation in 160 µl ACN for 5 min. ACN was removed and proteins were alkylated with 
100 µl iodacetamide for 20 min in the dark. Samples were washed 3 times with 200 µl 
ABC-buffer. Gel bands were dehydrated with 200 µl ACN and vacuum-dried. 
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20 µl of trypsin gold working solution was added to the samples and samples were re-
swollen for 10 min at 4°C.  Afterwards, trypsin solution was removed, samples were 
covered with ABC-buffer and tryptic digest was performed overnight at 37°C. On the 
next day, digestion was stopped by addition of 2 µl 10 % TFA. Peptides were extracted 
by sonication for 10 min in a sonication water bath. The peptide solution was transferred 
to a clean tube and the sonication step was repeated by addition of 10 µl 0.1 % TFA to the 
sample. The peptide extracts were pooled and stored at -80°C until they were subjected to 
nano-liquid chromatography matrix-assisted laser desorption-ionization (MALDI) - time 
of flight (TOF)/TOF (nanoLC-MS/MS) analysis. 
 
2.15.2 Identification of proteins by nanoLC-MS/MS 
Mass spectrometry analyses were performed at the Institut für Biochemie und molekulare 
Zellbiologie der Universität Wien at the Vienna Biocenter by Dr. Pichler.  
MS/MS spectra were matched against a custom generated database with Mascot version 
2.2 (Matrix Science). This database contained the protein sequences of P. amoebophila 
UWE25 and protein sequences availabe for other environmental chlamydiae. 
Additionally, it included protein sequences availabe for  Acanthamoeba sp. and the two 
relatives Dictyostelium discoideum and Entamoebae histolytica, whose genomes have 
been sequenced, as well as a list of frequently found contaminants in MS samples, like 
trypsin, keratins and BSA. 
 
2.16 Lipid bilayer measurements 
Lipid-bilayer measurments were performed at the laboratory of Prof. Roland Benz 
(Germany) as described before (58). Before addition to the aqueous phase, the samples 
containing pc1489 were diluted 1:100 in 1 % Genapol. 
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Fig. 5: Principles of lipid bilayer measurments. This technique is based on the increase in 
conductance measured if a channel-forming protein is incorporated in an aritificial lipid-bilayer 
(Fig.5, B and C). The apparature used consists of two chambers (cis- and trans-chamber) that are 
connected by a small circular hole (Fig.5, A). An artificial lipid-bilayer is formed across this hole, the 
protein to be investigated is added and pore-formation in the membrane is measured. Modified from 
(9). 
 
2.17 Fixation of cells 
Samples were fixed with PFA and methanol and the obtained results were compared. 
2.17.1 Fixation of cells with 4 % PFA 
 
Solutions 
4 % PFA in 1 x PBS  
1 x PBS  
 
Procedure 
Round cover slips were sterilized in ethanol, flame-sterilized and placed into each well of 
a multiwell-dish. Amoeba cultures were harvested and 1 ml of medium with uninfected 
amoebae or amoebae harbouring chlamydial endosymbionts was added to each well. 
Cells were allowed to attach overnight.  
The medium was removed and wells were washed with 500 µl 1 x PBS. 500 µl 4 % PFA 
in 1 x PBS were added to each well and cells were fixed for 1 hour at RT. The fixative 
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was removed and cells were covered with 1 x PBS. Fixed cells were stored in 1 x PBS up 
to 2 weeks at 4°C. 
 
2.17.2 Fixation of cells with Methanol 
 
Solutions 
Methanol 
1 x PBS  
 
Procedure 
Fixation procedure was the same as for fixation with 4% Paraformaldehyde (see 2.17.1), 
except that cells were fixed with methanol for only 10 min at RT. 
 
2.18 Immunofluorescence analysis and antibody preparation 
 
2.18.1 Preparation of antibodies targeting the putative porin pc1489 
 
Solutions 
Binding Buffer  
Elution Buffer  
Cleaning Buffer  
 
Procedure 
400 µg of pc1489 in Buffer A without n-POE were used for immunization of one 
chicken. Antibodies were produced by Eurogentec (Seraing, Belgium). Pre-immune egg 
yolks were collected before the first immunization. After the first immunization, 3 boosts 
followed. Egg yolks of the immunized chicken were collected, starting 8 days after the 
first immunization. 
IgY antibodies from different egg yolk collections and also from the pre-immune yolks 
were purified using a HiTrap™ IgY Purification HP column according to the 
manufacturer‟s instructions. 
 
2. Material and Methods 
54 
 
2.18.2 Preparation of amoeba lysate 
 
Solutions 
FA-Block solution  
 
Procedure 
An amoeba culture was harvested by centrifugation (5 min, 7,323 x g). The pellet was 
resuspended in 500 µl – 1 ml FA-Block solution, depending on the size of the pellet. 
Amoeba cells were broken by either 4 sonication steps for 30 seconds each or by two 
freeze-and-thaw steps (freezing at -20°C/ thawing at 42°C in a water bath). The resulting 
lysate was stored at -20°C until further use. 
 
2.18.3 Removal of antibodies targeting amoeba proteins 
To remove antibodies that would result in an unspecific background in 
immunofluorescence analysis, all sera used were inactivated against amoeba proteins. 
 
Procedure 
Antibody sera were mixed 1:1 with amoeba cell lysates, vortexed briefly and incubated 
overnight at 4°C. On the following day the solution was mixed and incubated again for 30 
min at 4°C. Amoeba cell debris that had bound the host-reactive antibodies was removed 
by centrifugation for 2 min at 6,797 x g. The supernatant was transferred to a new tube 
and used for further analysis.  
 
2.18.4 Immunofluorescence analysis  
 
Solutions 
1 x PBS  
10 mM Tris-HCl pH 6.5 
0.05% Tween
TM
 20 in 1 x PBS  
FA-Block solution  
Mowiol  
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Procedure 
For samples fixed with 4% PFA, a permeabilisation step was performed prior to 
immunofluorescence analysis in order to permeabilize cells.  
1 x PBS was removed and cells were incubated with 300 µl 0.05% Tween
TM
 20 in 1 x 
PBS for 25 min at room temperature. After removal of Tween
TM
 20, cells were covered 
with 300 µl 10 mM Tris-HCl (pH 6.5) containing 5 µg/ml Lysozyme and incubated for 1 
hour at room temperature. Permeabilized cells or cells fixed with methanol were 
incubated with FA-Block solution for 10 min. After this blocking step, the blocking 
solution was replaced with the primary antibody diluted in FA-Block solution and cells 
were incubated for 1 hour at RT. Cells were washed 3 times with 1 x PBS, followed by 
incubation with secondary antibody diluted in FA-Block solution for 1 hour in the dark. 
Cells were washed 3 times with 1 x PBS and cover slips were embedded in Mowiol. 
Embedded samples were analyzed by epifluorescence microscopy and confocal laser 
scanning microscopy. 
 
2.18.6 Immunofluorescence on thin sections 
  
Solutions 
1 x PBS  
FA-Block solution  
100 mM HEPES buffer, pH 7.2, with 2 % PFA and 0.1 % glutaraldehyde 
12 % gelatin 
Cryoprotective solution (2.3 M sucrose in 100 mM phosphate buffer) 
 
Procedure 
Thin sections (75 nm) of A. castellanii infected with P. amoebophila were provided by 
Jacqueline Monatanaro.  
Cells were fixed with 2% PFA, 0.1 % glutaraldehyde in 100 mM HEPES buffer (pH 7.2) 
for 20 mins at 20 C and then transfered to 2 % PFA in 100 mM HEPES buffer for a 
further 2 hours. Fixed cells were pelleted at 3000 x g and washed in 100 mM HEPES 
buffer. The cells were encapsulated in 12 % gelatin at 37 C. After 10 min infiltration, the 
cells were pelleted in an eppendorf tube and cooled on ice. The gelatin-cell pellet was cut 
into 0.1 mm
2
 cubes and infiltrated in Cryoprotective solution overnight at 4 C. Cell cubes 
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were mounted onto aluminium stubs and frozen in liquid nitrogen. Thin sections were cut 
using a Leica Ultracut UC6-FC6 ultramicrotome (Leica Microsystems, Austria) and 
mounted onto carbon-coated formvar-pilioform films supported on hexagonal 200 mesh 
nickle EM grids (Gilder, Netherlands). Sections were preserved prior to use under Cryo-
EM pick-up solution containing 1% methyl cellulose (Electron Microscopy Sciences, 
Germany)  and 1.3 M sucrose in 100 mM phosphate buffer at 4 C. 10 µl 1 x PBS were 
added to each well to solubilize methyl cellulose on top of the thin-sections. After 10 
minutes, 1 x PBS was replaced with 10 µl of the primary antibody diluted in FA-Block 
solution and cells were incubated for 1 hour at RT. Cells were washed 3 times with 10 µl 
1 x PBS, followed by incubation with 10 µl of the secondary antibody diluted in FA-
block solution for 1 hour in the dark. Cells were washed again and slides were embedded 
in Citifluor. Embedded samples were analyzed by epifluorescence microscopy and 
confocal laser scanning microscopy. 
 
2.19 Infection studies 
 
2.19.1 Counting of DAPI-stained cells 
The number of P. amoebophila cells in suspensions was determined by filtering cells onto 
a membrane, followed by DAPI-staining to visualize cells. 
 
Solutions 
1 x PBS (filter-sterilized)  
DAPI 
 
Procedure 
DAPI was prepared at a dilution of 1:10,000 and stored at 4°C until further use. 
Partially purified EBs were thawed at 37°C. 1 µl of the EB–suspension was added to 5 ml 
of filter-sterilized 1 x PBS and stored on ice. The filter device was flame-sterilized and 
assembled. 5 ml 1 x PBS were filtered to rinse the device by applying a vacuum pump 
running at 250 mmHg (millimetre of mercury). The bacterial suspension was filtered onto 
a 0.22 µm polycarbonate membrane filter and a 0.45 µm cellulose acetate membrane 
support underneath the filter. The device was rinsed with 5 ml 1 x PBS to wash down 
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bacteria bound to the glass funnel. 150 µl of DAPI solution were added on top of the filter 
and the filter was incubated for 5 min in the dark. The filter was washed with 1 x PBS, 
placed on a microscope slide and embedded in Citifluor. Samples were analyzed with an 
epifluorescence microscope. The number of cells on 10 x 10 fields on a grid was counted. 
The cell number/ml was calculated using the following formula: 
 
 
 
M …Microscope factor = 11,264  
DF … Dilution factor = 1,000 
2.19.2 Infection cycle 
 
Solutions: 
TSY  
1 x PAS (filter-sterilized)  
1 x PBS (filter-sterilized)  
4% PFA in 1 x PBS  
Methanol 
 
Procedure 
A large flask (150 ml) of A. castellanii Neff was harvested (sec. 2.9.2) and amoebae were 
counted using a Neubauer counting chamber. The number of amoebae/ml was calculated 
using the following formula: 
 
 
 
DF … Dilution factor = 100 
Depth of chamber = 0.1 mm 
 
After counting, amoebae were pelleted by centrifugation and resuspended in the volume 
of TSY needed to obtain the required number of cells/ml. Round cover slips were 
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sterilized in ethanol, flame-sterilizd and placed into each well of a multiwell-dish. 1 ml of 
TSY containing a defined number of amoebae was pipetted in the wells of the multiwell-
dish. Samples were incubated for 30 min – 60 min at 20°C to allow attachment of 
amoebae. Proper attachment of amoebae was controlled by light microscopy. Partially 
purified EBs were thawed at 37°C and placed on ice. Amoebae were infected with EBs at 
a multiplicity of infection (MOI) of 5 or a MOI of 10 by adding a defined amount of EB 
suspension to each well. Multiwell-dishes were centrifuged at 600 x g for 15 min at 20°C 
to enhance infection. The end of centrifugation was regarded as time point 0 hours post 
infection (h p.i.). After centrifugation, the medium was replaced with fresh TSY to 
remove excess EBs that were not attached to amoebae. Infected cultures were grown at 
20°C. At indicated time points, cells were fixed. For fixation, the medium was removed 
and cells were washed with 1 x PBS. Cells were fixed with 4% PFA or with methanol 
(2.18.1 and 2.18.2). The fixative was replaced by 1 x PBS and cells were stored at 4°C 
until immunofluorescence analysis was performed. 
 
2.19. 3 Heat inactivation of EBs 
Conditions for heat inactivation were chosen similar to those already published for heat 
inactivation of clinical chlamydiae (16). 
 
Procedure 
Partially purified EBs were thawed at 37°C and 1 volume of 1 x PBS was added. For heat 
inactivation, cells were incubated at 56°C for 30 min. 
 
2.19.4 Infection - inhibition assay using anti-Pam and anti-pc1489-antibody 
Infectious EBs were incubated with antibodies targeting the protein of interest and these 
EBs were then used for infection of host cells. The ability to attach to host cells and the 
number of bacteria/host cell were compared to non-treated EBs at certain time points. 
Anti-pc1489-antibody and anti-Pam-antibody, an antibody targeting the immunodominant 
proteins of the outer membrane of P. amoebophila, were used. 
 
Solutions 
TSY  
1 x PAS (filter-sterilized)  
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FA-Block solution (filter-sterilized)  
1 x PBS (filter-sterilized)  
4% PFA in 1 x PBS  
Methanol 
 
Procedure 
Anti-pc1489-antibody and anti-Pam-antibody were diluted in FA-Block solution to reach 
concentrations of 200 µg/ml and 20 µg/ml. Additionally,  a solution containing 200 µg/ml 
anti-Cld-antibody, targeting the Chloride dismutase of “Candidatus Nitrospira defluvii” 
(generously provided by Frank Maixner) was prepared. 
EBs and heat-inactivated EBs were incubated with 20 µg/ml or 200 µg/ml of anti-
pc1489-antibody or anti-Pam–antibody for 30 min at 37°C. As controls, EBs and heat –
inactivated EBs were incubated with FA-Block solution only and additionally, EBs were 
incubated with 200 µg/ml anti-Cld-antibody under the same conditions. Amoebae were 
infected to obtain a final MOI of 5 as described above (sec. 2.19.2). Infections were done 
in duplicates. One of these duplicates was fixed with methanol, the other with 4% PFA 
(sec. 2.18.1 and sec. 2.18.2). The following time points were investigated: 0, 6, 12, 24, 
48, 72 and 96 hours post infection. After fixation of cells, multiwell-dishes were stored at 
4°C until immunofluorescence analysis was performed. Samples were examined by 
fluorescence microscopy and the number of infected amoebae at 72 and 96 h p.i. was 
counted. The ratio of infected amoebae to all amoebae counted was calculated to allow a 
comparison of infectivity of treated and non-treated EBs. 
 
 
2.15 Heterologous expression of proteins in Escherichia coli 
 
2.15. 1 Overexpression of proteins 
Vector-constructs used in this study are listed in table 8 and were provided in the E. coli 
expression strain BL21 (DE3) by Eva Heinz. 
 
Solutions 
LB medium  
Ampicillin  
1 M Isopropyl-β-D-thiogalactopyranosid (IPTG) in H2Odd, filter-sterilized 
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4 x SDS - PAGE loading buffer 
Procedure 
5 ml of LB medium were inoculated with E. coli cells from a glycerol stock and grown 
overnight at 37°C. Recombinant E. coli cells harbouring a plasmid were grown in the 
presence of ampicillin to avoid the growth of cells without a plasmid. 250 µl of the 
overnight-culture were used to inoculate 5 ml of fresh LB medium and cells were grown 
for 2 hours at 37°C. Expression of proteins was induced by addition of IPTG to obtain an 
end concentration of 1 mM to the culture. After 6 hours, cells were harvested by 
centrifugating 300 µl of the culture at 17,949 x g for 2 min. The pellet was resuspended in 
60 µl of 4 x SDS - PAGE loading buffer and analysed by SDS-PAGE analysis (sec. 
2.10.4). 
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3. Results 
 
3. 1 Purification of the putative porin pc1489 
The putative porin pc1489 was purified from elementary bodies of P. amoebophila. The 
different fractions obtained after applying a NaCl-gradient to the anion-exchange column 
were controlled on a SDS-PAGE gel. In the fractions after solubilisation and precipitation 
of proteins (Fig.6, lanes 1 and 2), a high number of different proteins was present. In lane 
3, the flow-through fraction, one band at ~ 50 kDa can be observed. This band represents 
the OmcB homologue pc0616 that was identified in a previous study by mass 
spectrometry analysis of gel bands (47). A prominent band corresponding to pc1489 is 
present in lanes 1 and 2 at ~30 kDa and also in lanes 5-9, corresponding to the eluates of 
the 250 mM, 300 mM, 350 mM and 400 mM NaCl- fractions. The molecular weight of 
the observed band is not in accordance with the predicted weight of pc1489 (36 kDa), but 
outer membrane proteins have been reported to migrate abnormally in SDS-PAGE gels 
(see sec. 3.3). Only very weak additional bands are present in lanes 6, 7 and 8, showing 
that pc1489 is highly enriched in these fractions. For some purifications, up to 7 bands 
could be observed in the eluate after applying 350mM NaCl, suggesting the presence of  
 
Fig. 6: Typical gel to check the purity of pc1489 after purification. Bands for OmcB (upper arrow) 
and pc1489 (lower arrow) are indicated. M:Marker; Lane 1: Proteins after incubation at 37°C; Lane 
2: Proteins after precipitation with acetone; Lane 3: Flow-through after applying the sample to the 
column; Lane 4: Eluate after applying 100 mM NaCl; Lane 5: Eluate after applying 250 mM NaCl; 
Lane 6: Eluate after applying 300 mM NaCl; Lane 7: Eluate after applying 350 mM NaCl; Lane 8: 
Eluate after applying 400 mM NaCl; Lane 9: Eluate after applying 550 mM NaCl; Weight of marker 
proteins in kDa is indicated on the left. 
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various other proteins than pc1489 in these fractions. Fractions  where strong additional 
bands to that at 30 kDa were observed, were not used for production of antibodies or lipid 
bilayer measurements. After the second precipitation step, samples were highly enriched 
in pc1489 as can be seen by the presence of a strong band at 30 kDa in Fig.7 (left and 
central picture). In the enriched fractions, bands were visible at 55 kDa, 60 kDa and 70 
kDa. To see whether these bands represent pc1489 and to identify other proteins present 
in these bands, they were subjected to analysis by mass spectrometry. 
 
Fig. 7: SDS-PAGE gels of pc1489 after the second precipitation step (left and central picture) and of a 
second, independant purification of pc1489 (right picture). Bands analyzed by mass spectrometry are 
indicated by red circles and numbers correspond to table 13. For these scanned images, the contrast 
was enhanced. Weight of marker proteins in kDa. 
 
3.2 Analysis of bands of interest by mass spectrometry 
In total, 12 bands of two independent purifications of pc1489 were analysed. 
Pc1489 was the most abundant protein in most bands in Fig.7. It was present in high 
amounts in the band at 30 kDa and also in the bands at 55 kDa, 60 kDa and 70 kDa (table 
13). The presence of pc1489 in various bands suggests formation of multimers by pc1489 
as found in porins of Gram-negative bacteria or interaction with other proteins of the 
outer membrane. The bands at higher molecular weights could represent the dimeric and 
trimeric form of pc1489 comparable to those observed for MOMP of Chlamydiaceae 
(74). MOMP has been reported to run at a molecular weight of 90 kDa, representing the 
porin trimer, when loaded on gels without heating the sample (110).  However, for  
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Band Protein Function/ Similarity to known 
proteins* 
Signal peptide 
predicted** 
1 pc1885 homologue of OmpW yes 
 pc1077 putative porin yes 
 pc1974 unkown protein yes 
2 pc1489 putative porin yes 
 pc0383 similar to macrophage infectivity 
potentiator (Mip) 
yes 
 pc1499 similar to DnaK (heat shock 
protein) 
no 
3 pc1489 putative porin no 
 pc1077 putative porin yes 
4 pc0383 similar to Mip yes 
 pc1077 putative porin yes 
 pc1885 homologue of OmpW yes 
5 pc1771 similar to citrate -synthase no 
 pc1105 conserved hypothetical protein no 
 pc1489 putative porin yes 
6  pc1489 putative porin yes 
 pc1180 strongly similar to 60 kDa 
chaperonin GroEL 
no 
 ACL00009089 *** amoeba protein no 
7 pc1489 putative porin yes 
 pc0675 hypothetical protein yes 
 pc1070 unknown yes 
8 pc1489 putative porin yes 
 pc1077 putative porin yes 
 pc1885 homologue of OmpW yes 
9 pc1489 putative porin yes 
 pc1077 putative porin yes 
 pc0004 hypothetical protein no 
10 pc1885 homologue of OmpW yes 
 pc1489 putative porin yes 
 pc1077 putative porin yes 
11 pc1489 putative porin yes 
 pc1885 homologue of OmpW yes 
 pc1077 putative porin yes 
12 pc1489 putative porin yes 
 ACL00000461*** mitochondrial porin from A. 
castellanii 
no 
 pc1077 putative porin yes 
Table 13: Proteins identified by mass spectrometry in analyzed bands. For each band, only the 3 hits 
with the highest protein score are listed. Rows coloured grey were identified in a previous studies in 
outer membrane fractions (47). 
 * according to http://mips.gsf.de/genre/proj/uwe25/ 
** according to TargetP (29)  
*** according to http://tbestdb.bcm.umontreal.ca  
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MOMP, no band for the monomer can be observed under these conditions in contrast to 
pc1489, where the monomer is the most prominent band.In the fraction after elution with 
350 mM NaCl, results indicated a considerable contamination with other proteins. 
Proteins that were identified by mass spectrometry are listed in Table 13. Most of the 
proteins identified by mass spectrometry were predicted to harbour a signal peptide 
according to TargetP, indicating a localization in the outer membrane, and were found in 
preparations of the outer membrane of P. amoebophila in a previous study (47). 
 
3.3 Heat modifiability of pc1489 
When pc1489 was applied to SDS-PAGE 
gels in loading buffer without DTT and 
without heating, the major band for the 
protein was found at a weight of ~30 kDa 
and additional weak bands were 
observable at ~55 kDa and ~ 70 kDa 
(Fig.8, lane 1). According to in  silico 
predictions, pc1489 should have a 
molecular weight of 36 kDa. The 
migration behaviour didn‟t change in the 
presence of the reducing agent DTT (lane 
2). However, when samples were heated 
to 95°C prior to loading, the band pattern 
changed considerably. In addition to the 
band at 30 kDa, bands appeared at ~ 36 kDa and ~15 kDa. The upper band at 36 kDa 
could represent pc1489 migrating at its correct size after boiling, whereas the lower band 
could be a degradation product or a cleaved form of pc1489. This change in band patterns 
was even more pronounced in the presence of DTT. As the band at 55 kDa visible in 
lanes 1 and 2 got weaker in lane 4, the higher amount of protein at 36 kDa could be 
related to breaking up of a multimer of pc1489 or breaking of crosslinks between proteins 
by heating in the presence of DTT. 
 
 
Fig. 8: Heat modifiability of pc1489 demonstrated 
by the appearance of a band at a higher molecular 
weight after heating of samples to 95°C. Contrast 
was enhanced. Molecular weight marker in kDa. 
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3.4 Western blot analysis of pc1489 
The specificity of purified anti-pc1489-antibody was tested by Western Blot analysis. 
Western Blot analysis showed specific detection of purified pc1489 by the antibody, 
indicated by the presence of one distinct band at ~ 30 kDa. Additional weak bands were 
present at ~ 55 kDa and ~ 70 kDa (Fig.9 A). As pc1489 has been identified in bands of 
this weight by mass spectrometry (see sec.3.2), these additional bands could result from 
detection of pc1489 by the antibody. Samples with equal amounts of proteins of 
uninfected A. castellanii, A. castellanii infected with P. amoebophila and purified EBs of 
P. amoebophila were loaded on gels and Western blot analysis was performed. As these 
samples had to be heated prior to loading on the gel in order to break up cells, the signal 
for pc1489 was expected at ~ 36 kDa.  
In samples containing amoebae without symbionts, no band was observed by Western 
blot analysis, showing that the anti-pc1489-antibody does not cross-react with amoeba 
proteins (Fig.9 B, lane 2).  
In samples of A. castellanii infected with P. amoebophila, several bands were detected 
(Fig.9 B, lane 1). One prominent band was found at ~ 60 kDa, and a weak signal was  
Fig. 9: Western blot analysis with anti-pc1489-antibody. A: Detection of a band at the correct size in 
SDS gels with purified pc1489 shows specificity of anti-pc1489-antibody. B: Detection of multiple 
bands in A. castellanii infected with P. amoebophila. Lane 1: A. castellanii infected with P. 
amoebophila; Lane 2: Uninfected A. castellanii; Lane 3: Purified EBs of P. amoebophila. For 
comparison, a SDS gel with samples applied like in B and stained with colloidal Coomassie is shown 
in C. Molecular weight marker in kDa. 
A  B C 
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present from 35 kDa to 50 kDa. The smear might represent the monomeric form of 
pc1489 after heating to 95°C which results in several bands at these molecular weights 
(see sec 3.3). The band at 55 kDa could represent a multimer of pc1489 or the protein 
pc1489 cross linked to other proteins in the outer membrane of EBs and RBs as both 
developmental forms were present in asynchronized cultures used for this experiment. 
The band at 20 kDa could result from degradation products of pc1489. In a study by 
Heinz et al. (47), pc1489 was detected in bands of various molecular weights in outer 
membrane fractions of P. amoebophila, supporting the detection of several bands by anti-
pc1489-antibody in amoebae infected with P. amoebophila.  In EBs, only one prominent 
band was observable at ~55 kDa (Fig.9 B, lane 3), possibly representing a tightly cross 
linked multimer of pc1489. 
3.5 Immunofluorescence analysis of pc1489 
The localization of pc1489 in P. amoebophila during co-existence with its host was 
studied by immunofluorescence analysis. Anti-pc1489-antibody was used simultaneously 
with anti-Pam and anti-Hsp60-antibodies. Anti-Pam-antibodies were raised against whole 
elementary bodies of P. amoebophila and therefore target the immunodominant 
components of the outer membrane. Anti- Hsp60-antibodies target the chlamydial heat-
shock protein GroEL that is located in the cytoplasm and in the outer membrane of 
chlamydiae (120). 
Signals for pc1489 showed a halo-like shape and overlapped with signals for the outer 
membrane of P. amoebophila by anti-Pam-antibody in methanol and PFA-fixed samples 
(Fig.10). Signals observed for the cytoplasmic protein Hsp60 were surrounded by pc1489 
(Fig.11 B). The halo-shape of signals was even more evident when immunofluorescence 
was performed on thin-sections (Fig.11 A). The shape of the signal for pc1489 indicates a 
localization of this protein in either the inner or the outer membrane or in the inclusion 
membrane of P. amoebophila. As P. amoebophila thrives in single cell-inclusions in its 
host, the inclusion membrane is adjacent to the outer membrane. Differentiation between 
signals of the outer membrane and the inclusion membrane is not possible by 
immunofluorescence analysis. Hsp60 was detected mostly in the cytoplasm of bacteria, 
but also a few halo-like shaped signals could be observed, consistent with recent reports 
that Hsp60 is also located to the outer membrane (120). 
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No fluorescent signal was observed in uninfected amoebae for any of the antibodies used, 
although an elevated level of background noise/signal could be observed for the anti-
Pam-antibody (Fig.10).  
Serum of pre-immune egg yolks gave no signal in uninfected and in amoebae infected 
with P. amoebophila (data no shown). No differences in the shape of the signal could be 
observed for methanol and PFA-fixed samples (data not shown). 
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Fig. 10: Immunofluorescence analysis using preI-pc1489 and pc1489-antibody. No signal is observed 
for the pre-immune serum in infected amoebae or for pc1489 in uninfected amoebae. Differential 
interference contrast (DIC) channel is shown for better overview.  Rows 1-4 represent identical 
microscopic fields.  Bars 5 µm. 
3. Results 
68 
 
 
A         anti-pc1489 overlay B 
  
  
 
Fig. 11: A: Immunofluorescence analysis of thin-sections (75 nm). Detection of pc1489 (red) gives 
halo-shaped signals with anti-pc1489-antibody. Left: Detection of pc1489 by anti-pc1489-antibody. 
Right: Overlay of DIC and anti-pc1489-antibody; Bar 2 µm 
 B: Detection of P. amoebophila by anti-pc1489-antibody (red, upper left) and anti-Hsp60-antibody 
(green, upper right). Signals for pc1489 surround those for Hsp60 in an overlay (bottom). Bars 1 µm 
 
3.6 Detection of proteins homologous to pc1489 in other chlamydia-like 
bacteria 
Signals resembling those observed for P. amoebophila E25 were seen in 
immunofluorescence analysis of samples of P. amoebophila EI2. Pc1489 showed halo-
shaped signals overlapping with signals of anti-Pam-antibody, indicating presence of a 
pc1489-like protein in this strain (Fig.12).  
In immunofluorescence analysis of P. acanthamoeba UV7, only a weak signal could be 
detected in a subset of bacteria with anti-pc1489-antibody (Fig.13). In most cases, signals 
for Hsp60 did not overlap with signals for serum raised against EBs of P. acanthamoeba. 
Signals for pc1489 did not localize with signals for anti-UV7-antibody, but seemed to 
surround mainly signals for Hsp60. No signals were observed with the pre-immune serum 
of anti-pc1489-antibody (data not shown) 
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Fig. 12: Immunofluorescence analysis to detect pc1489 in other chlamydia-like bacteria. Upper panel: 
Detection of P. amoebophila EI2 by anti-Pam-antibody (green) and anti-pc1489-antibody (red). 
Lower panel: Detection of P. acanthamoeba UV7 by anti-pc1489-antibody. For P. acanthamoeba UV7, 
an overlay of signal by Hsp60 (blue) and signal given by anti-UV7-serum (green) is shown in the first 
column  in order to show that these two antibodies detect different subsets of bacteria in amoebae. 
Differential interference contrast (DIC) channel is shown on the right. Rows 1-4 represent identical 
microscopic fields.  Bars 5 µm 
. 
3.7 Expression of pc1489 during an infectious cycle 
At 0 hours post infection (h p.i.), pc1489 could be detected by immunofluorescence 
analysis, giving a strong but not well-defined signal and indicating the presence of this 
protein in the infectious EBs (Fig.13). Signals for pc1489 were observed throughout the 
whole infection cycle for all chlamydiae present, with the halo-like shape getting better 
defined around 6 h p.i. Signal intensity increased slightly at later time points. Anti-Pam-
antibody resulted in a high unspecific background, especially at early time points of the 
infection (0 h p.i. – 6 h p.i.). Therefore, this antibody seems to bind amoeba proteins 
despite pre-treatment with amoeba lysates. As this antibody was raised against EBs 
purified from amoebae, it seems possible that not all amoeba proteins were removed 
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during purification of EBs, thereby giving rise to antibodies targeting proteins of 
amoebae. The unspecific background got lower at later time points and halo-shaped 
signals of anti-Pam-antibody overlapped with signals for Hsp60 and pc1489. Only very 
weak signals could be observed for the heat shock protein Hsp60 at early time points. 
Signals for Hsp60 at 0 h p.i. showed a halo-like shape, pointing to the presence of a low 
amount of this protein in the outer membrane of EBs. Very weak signals could be seen 
for Hsp60 up to 24 h p.i., with a strong increase in signal intensity at 48 h p.i. From 48 h 
p.i. to 96 h p.i., nearly all chlamydiae labelled with anti-Pam-antibody and anti-pc1489-
antibody were also detected by anti-Hsp60-antibody and gave a strong signal. Signals for 
Hsp60 were surrounded by signals for pc1489 at later time points. Expression of Hsp60 
seems to be up-regulated significantly after conversion of EBs in metabolically active 
RBs as indicated by the rise of signal for this protein. At later time-points, sometimes 
enlarged chlamydiae were seen in amoebae (Fig.14), maybe indicating stress due to 
depletion of iron or other nutrients. 
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Fig. 13: Infection cycle of P. amoebophila in A. castellanii.  P. amoebophila cells were detected with 
anti-Pam-antibody (blue), anti-Hsp60-antibody (green) and anti-pc1489-antibody (red). Amoeba cell 
outline are indicated in white. Numbers on the left indicate hours post infection. Rows 1-4 represent 
identical microscopic fields. Bars 5 µm 
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Fig. 14: Enlarged chlamydiae at  96 h p.i. Comparison with Fig.13 shows that chlamydiae are 2-4 
times larger than normally. Bars 5 µm 
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3.8 Porin activity of pc1489 
 
Lipid-bilayer measurments were 
performed at the laboratory of Prof. 
Roland Benz (Würzburg, Germany). 
Single-channel analysis showed that 
pc1489 formed channels in a lipid 
bilayer, indicated by a step-wise increase 
in the measured conductance after 
addition of pc1489 to the lipid bilayer 
(Fig.15). The single channel conductance 
was 3.25 nS in 1 M KCl. The 
dependence of the single-channel 
conductance on the KCl-concentration 
(Table 14) suggested that ions can pass 
the formed channel easily, indicating the 
presence of a large water-filled pore in 
the membrane.  
The single-channel conductance was 
shown to be more dependent on the 
aqueous mobility of anions than of 
cations. Replacement of the mobile Cl
-
 
ion by the less mobile acetate-ion 
resulted in a 2.1 –fold decrease in 
conductance, whereas replacement of the 
mobile K
+
 -ion by the less mobile Li
+
 -
ion resulted in a 1.4 decrease.  
These results indicate selectivity of the 
pc1489-channel for anions. Anion 
selectivity of the porin was confirmed by 
additional measurements and calculation 
of the Pc/Pa- ratio using the 
 
 
 
Fig. 15: Single-channel analysis of purified pc1489 
in 1 M KCl. Each step indicates insertion of one 
pore in the lipid bilayer.  Conductance in nS and 
time in seconds 
 
 
Salt Concentration 
(M) 
Single-channel 
conductance 
(nS) 
KCl 0.01 0.15 
KCl 0.03 0.25 
KCl 0.1 0.6 
KCl 0.3 1.2 
KCl 1 3.25 
KCl 3 11 
LiCl 1 2.25 
KAc 1 1.5 
Table 14:  Single channel conductance of pc1489  
in different salt solutions 
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Goldman-Hodgkin-Katz equation (10). This equation shows the ratio of the permeability 
coefficient for a cation (Pc) in relation to the permeability coefficient  
for an anion (Pa) for a porin. A value for Pc/Pa > 1 indicates selectivity for cations of a 
channel, Pc/Pa < 1 indicates selectivity for anions and if Pc/Pa = 1, a channel is not 
selective regarding the chosen anion or cation (46). Pc/Pa – ratios were 0.48 for KCl, and 
0.78 for LiCl. All calculated Pc/Pa – ratios are smaller than 1, confirming selectivity of 
pc1489 for anions. 
A typical feature of porins is closure of the pore if high voltage is applied. Channels 
formed by pc1489 showed closure for both positive and negative potentials of 30 mV and 
-30 mV, shown by a decrease in conductance (Fig.16). Closure behaviour of pores did 
only slightly change if pc1489 was added only to the trans- or to the cis-chamber of the 
apparature in a way that closure was observed at a voltage of 40 mV and -40 mV. These 
results indicate a symmetric response of the pore to the voltage applied and thereby 
suggest the formation of a symmetrical pore by pc1489. 
  
  
Fig. 16: Ratio of the conductance G at a given potential (Vm) divided by the conductance Go at 10 mV 
as function of Vm. The aqueous phase contained 1 M KCl. The obtained graph shows voltage 
dependent closure of pores formed by pc1489 as seen by a decrease in the measured conductance. 
Channels closed if pc1498 was added on both sides (left) or only to the cis-chamber of the apparature. 
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3.9 Heat inactivation of EBs 
It has been demonstrated in previous studies that incubation of infectious EBs at 60°C for 
a period of times as short as 3 min results in a dramatic decrease in attachment to and 
uptake by host cells for some members of the Chlamydiaceae (80).  
The effect of incubation at 56°C for 30 min on P. amoebophila was tested.  
Non-treated and heat treated EBs were compared concerning their uptake by amoebae as 
well as their ability to multiply within the amoeba host cells. No difference for uptake by 
amoebae and the following 6 h p.i. and 12 h p.i. time points could be noticed (Fig.17, 0 
and 6 h p.i.). At 24 h p.i., dividing chlamydiae could be seen in non-treated samples, 
although differentiation between heat treated and non-treated bacteria was still difficult. 
The number of bacteria in infected host cells started to rise clearly at 48 h p.i. in non-
treated samples, accompanied by an increase in signal for the heat-shock protein Hsp60. 
Heat treated P. amoebophila cells appeared unable to divide, as numbers of bacteria per 
host-cell dropped instead of increasing. Additionally, no gain in Hsp60 signal was seen 
for the heat treated sample. This got even more obvious for the following time points, 
where non-treated chlamydiae continued multiplying and filled the host cell, whereas 
signals for treated chlamydiae could only be observed for single cells in a few amoebae. 
The shape of signals for heat treated cells was well defined up to 72 h  p.i., but got diffuse 
at 96 h p.i., suggesting slow digestion of heat-inactivated chlamydiae by amoebae. 
The obtained results suggest that heat-inactivation of EBs does not inhibit uptake of P. 
amoebophila by amoebae, but renders chlamydiae unable to multiply within their host 
cells.  
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Fig. 17: Infection cycle with heat-inactivated EBs. Rows 1-3 represent identical microscopic fields for 
infection with heat treated EBs. On the far right, infection with non-treated EBs is shown for 
comparison (Hsp60 in green, pc1489 in red) and for this control, amoeba cell outline are indicated in 
white. Numbers on the left indicate hours post infection. Bars 5 µm 
3.9 Infection inhibition assay 
 No difference in uptake or the ability to multiply within host cells could be observed 
between EBs incubated with antibody and the control (Fig.18). For samples incubated 
with 200 µg/ml anti-Pam-antibody, this high concentration of antibody lead to 
agglutination of EBs. This resulted in large aggregates of EBs that were taken up by 
amoebae in contrast to other samples, where EBs did not stick together. These aggregates 
of chlamydiae were observed up to 48 h p.i. in samples treated with 200 µg/ml anti-Pam-
antibody. However, agglutination did not seem to influence multiplication of P. 
amoebophila within host cells as an increase of signal for Hsp60 could be observed for 
chlamydiae within these aggregates in contrast to heat-inactivated EBs (Fig. 20). 
At 72 h p.i., no aggregates were observable any more. The number of amoebae infected 
after 72 h p.i. and 96 h p.i. showed no difference between EBs treated with the low 
concentration of anti-Pam-antibody and the controls (Fig.19). However, in samples of 
EBs treated with the higher anti-Pam-concentration, the percentage of infected amoebae 
was even higher than that of the control. However, these results have to be treated with 
caution, as no duplicates could be investigated for some time points for samples incubated 
with 200 µg/ml anti-Pam-antibody as no amoebae were found on the slides fixed with 
PFA. Pre-incubation with anti-pc1489 did not show any effect on infectivity of 
chlamydiae even at high concentrations. The number of infected amoebae was 
comparable to that observed for untreated EBs and the EBs incubated with anti-Cld-
antibody. No effect of incubation with anti-Cld-antibody, targeting the chloride dismutase 
of "Candidatus Nitrospira defluvii" that is not be present in P. amoebophila, was 
observable. Heat-inactivated EBs were taken up by amoebae and did not multiply as 
expected. No differences in uptake after incubation with antibodies were observable. 
Heat-inactivated EBs incubated with high concentrations of anti-Pam-antibody did not 
agglutinate and no large aggregates of chlamydiae could be seen. It is possible that 
treatment of EBs at 56°C leads to denaturation of heat-sensitive target sites of this 
antibody, resulting in lower amounts of anti-Pam-antibody bound to EBs and thus EBs do 
not aggregate. 
These results suggest that pre-treatment of EBs with anti-Pam-antibody or anti-pc1489-
antibody does not inhibit infection of amoeba host cells. However, as not all samples 
from all time points contained amoebae, these results have to be validated by further 
experiments.  
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Fig. 18: Infection inhibition assay with anti-Pam-, anti-pc1489- and anti-Cld-antibody for 0 h p.i. and 
12 h p.i. Signals for pc1489 and an overlay for pc1489 with the DIC-images is shown. Bars 5 µm 
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Fig. 19: Infection inhibition assay with anti-Pam-, anti-pc1489- and anti-Cld-antibody for 48 h p.i. 
and 96 h p.i. Signals for pc1489 and and an overlay for pc1489 with DIC-images is shown. Rows 1 
and 2 as well as rows 3 and 4 represent identical microscopic fields.  In row 3, the outlines of 
uninfected amoebae are indicated in white. Bars 5 µm for pictures on the left and 10 µm for pictures 
in the right panel. 
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anti-Pam anti-Hsp60 anti-pc1489 partial overlay 
    
Fig. 20: Activity of huge lumps of chlamydiae taken up by amoebae after preincubation with 200 
µg/ml anti-Pam-antibody is shown at 48 h p.i. by increase in Hsp60-signal for these bacteria. On the 
right, the DIC-channel and the signal of anti-pc1489 is shown in an partial overlay. Bars 5 µm 
 
3.10 Western blot analysis of Incs 
The specificity of antibodies against putative Inc - proteins of P. amoebophila was tested 
by the reaction to lysates of E. coli cells heterologously expressing the Inc-proteins. 
Lysates of E. coli without plasmid were used as negative control. All antibodies detected 
their target protein. Sera against pc0156, pc0399 and pc0577 showed strong and specific 
detection indicated by a strong band at the correct size and almost no background signals. 
Antibodies targeting pc0530 and pc1111 also showed strong signals for their target 
proteins, but bound also unspecifically to proteins of E. coli, resulting in several 
unspecific bands (Fig.21). As proteins for immunization of animals were expressed in E. 
coli and purified via a His-tag (47), histidine-rich proteins of E. coli might have bound to 
the column during purification of the overexpressed proteins and been eluted with the 
Inc-proteins. Upon immunization of animals, these contaminating proteins would give 
rise to antibodies targeting histidine-rich proteins of E. coli.  
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pc0156 pc0399 pc0399 (Coomassie) 
   
 
pc0530 pc0577 pc1111 
   
Fig. 21: Western blots showing the specificity of anti-Inc-antibodies to parts of putative Inc-proteins 
expressed in E. coli. Lysates of E. coli expressing the Inc-proteins are indicated with +, E. coli cells 
without expression vector with -. Bands for Inc-proteins are indicated by arrows. For pc0399, a SDS 
gel stained with Coomassie is shown for comparison. Molecular weight marker in kDa on the left of 
each picture. 
 
3.11 Immunofluorescence analysis with anti-Inc-antibodies 
Immunofluorescence analysis showed halo-shaped signals for pc0156, pc0399, pc0530 
and pc1111 overlapping with signals of anti-Pam-antibody. Anti-pc0399-antibody and 
anti-pc0156-antibody bound to all bacteria detected with anti-Pam-antibody, whereas 
pc0530 and pc1111 were detected in only a subset of bacteria (Fig.22). All antibodies 
resulted in a high unspecific background even though sera were inactivated against 
amoeba proteins several times. Pre-immune sera also yielded high unspecific background, 
but no defined signals were observed. Signals for pc0577 were difficult to distinguish 
from the high background and were observed in the cytoplasm or the outer membrane.  
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Fig. 22: Immunofluorescence analysis with antibodies targeting the putative Inc-proteins of P. 
amoebophila. Rows 1-3 indicate identical microscopic fields. Bars 5 µm 
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Differences compared to the pre-immune serum were hard to see for this protein (data not 
shown).As stated above, differentiation between signals for proteins in the inner 
membrane, the outer membrane and the inclusion membrane is not possible by 
immunofluorescence analysis in P. amoebophila. To get additional proof for the 
localization of the putative Inc-proteins in the inclusion membrane, highly-purified 
elementary bodies fixed with methanol were investigated by immunofluorescence 
analysis. During high-purification of EBs, the inclusion membrane should be removed as 
observed by transmission electron microscopy. Highly-purified EBs gave a strong signal 
with anti-Pam-antibody, but no signal could be observed for the putative Inc-proteins 
(Fig.23). These results support the localization of these proteins to the inclusion 
membrane of P. amoebophila.  
 
Inc protein pc0156 pc0399 pc0530 pc1111 
 
anti-Inc 
and anti-
Pam 
    
Fig. 23: Immunofluorescence analysis of highly-purified EBs of P. amoebophila with anti-Pam-
antibody and antibodies targeting four of the putative Inc-proteins. Signals can be seen for anti-Pam-
antibody (blue), but not for Inc-proteins (red), because the inclusion membrane is removed during 
purification. Bar 2 µm 
 
 
 
 
4. Discussion 
84 
 
 4. Discussion 
 
4.1 Characterization of pc1489 
4.1.1 Localization of pc1489 
MOMP, a porin with a mass of 40 kDa, is the most abundant component in the outer 
membrane of Chlamydiaceae (15), but interestingly there is no homologous gene encoded 
in the genome of P. amoebophila (19). In a recent study that combined 1D- and 2D- gel 
electrophoresis with mass spectrometry, a family of putative porins was identified in 
outer membrane preparations of the chlamydia-like bacterium P. amoebophila. The 
prediction of a beta-barrel structure and the high abundance in preparations of the outer 
membrane suggested that the two proteins pc1489 and pc1077 function as porins and act 
as functional replacement of the major outer membrane protein of Chlamydiaceae in P. 
amoebophila (47).  
In this study, antibodies were raised against pc1489 purified from elementary bodies of P. 
amoebophila. Immunfluorescence demonstrated the localization of this protein in the 
inner, outer or inclusion membrane of P. amoebophila by forming a halo-shaped signal 
surrounding the bacteria. Localization of pc1489 to the outer membrane was supported by 
heat modifiability of this protein. Heat modifiability is considered to be a hallmark feature 
of outer membrane proteins and has been studied in detail for several outer membrane 
proteins like OmpA from E. coli (7) or outer membrane proteins of Rhodopseudomonas 
sphaeroides (64). Due to their high beta-sheet content, outer membrane proteins bind 
unusually high amounts of SDS. This results in faster migration through the gel compared 
to other proteins leading to an underestimation of the weight of the protein. However, 
excessive binding of SDS is reduced by boiling and therefore heating of the samples leads 
to migration of the protein at the correct size. This behaviour is suggested to result from 
the conversion of beta-sheets to alpha-helices by heating (85). Pc1489 was migrating at 
30 kDa without heating, but an additional band appeared at 40 kDa after heating, showing 
that the migration behaviour of this protein changes upon heating. This heat modifiability 
of pc1489 suggests a high beta-sheet content of this protein as also has been proposed by 
in silico analysis (47) and points to a localization in the outer membrane of P. 
amoebophila. 
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The final proof of a localization of pc1489 to the outer membrane has recently been given 
by immuno-transmission electron microscopy studies by Jacqueline Montanaro. Gold 
particles are located at the membrane of P. amoebophila, but not the inclusion membrane 
or the  
cytoplasm of the bacterium (Fig. 24). To investigate the presence of a homologue of 
pc1489 in a member of the same family but different genus than P. amoebophila, 
immunofluorescence was performed with P. acanthamoeba.  The detection of a signal in 
a subset of bacteria is well-supported by the identification of a homologue of pc1489 by 
in silico analysis in P. acanthamoeba, suggesting the recognition of a protein similar to 
pc1489 in this bacterium by the anti-pc1489-antibody. This protein could be identical 
with the one identified by in silico analysis and assigned to the same Pfam domains as 
members of the putative porin family of P. amoebophila (pc0870, pc1077, pc1489 and 
pc1860) was identified (47). The detection of a protein in P. acanthamoeba by anti-
pc1489-antibody is rather surprising, as antibodies against MOMP are often strain-
specific in clinical chlamydiae and serovar-specific in C. trachomatis, where they are 
used for serotyping (102, 104).  
The low number of detected cells could be the result of differences in the organisation of 
the outer membrane in EBs and RBs of P. acanthamoeba, for example due to extensive 
cross linking of proteins in EBs that would mask binding sites for the anti-pc1489-
antibody in proteins of the outer membrane. This hypothesis is supported by the finding 
  
Fig. 24: Pictures taken by transmission electron microscopy using anti-pc1489-antibody (left) and pre-
immune serum (right). Bars 200 nm. Pictures courtesy of Jacqueline Montanaro 
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that serum raised against whole EBs and therefore targeting proteins of the outer 
membrane of EBs only binds to a subset of bacteria, presumably EBs in 
immunofluorescence analysis (Fig.12). It is also possible that the antibody does not fit the 
protein detected in P. acanthamoeba perfectly and therefore less of the antibody is bound, 
leading to fewer cell being detected. To investigate this further, Western blot analysis 
with samples of P. acanthamoeba should be performed and differences in band patterns 
between purified EBs and bacteria isolated at a time point in the developmental cycle 
when mainly RBs are present, should be compared. It will be also interesting to contrast 
band patterns of P. acanthamoeba with P. amoebophila. 
Pc1489 was shown to be present in P. amoebophila throughout the whole developmental 
cycle, demonstrating the presence of this protein in EBs and RBs comparabe to MOMP of 
Chlamydiaceae. The observed increase in signal intensity at later time points could be the 
result of incorporation of newly synthesized pc1489 into the outer membrane, thereby 
increasing the amount of pc1489 present. It could also result from changes in the structure 
of pc1489 which lead to better binding of anti-pc1489-antibody to its target protein or be 
due to different fixation behaviour of different samples. 
 
4.1.2 Functional characterization of pc1489 
In SDS-PAGE gels with purified pc1489 and also in Western blot analysis, weak bands at 
55-60 kDa were observed in addition to bands at 30 kDa or 40 kDa. This raises the 
question about the organization of pc1489 in the outer membrane of P. amoebophila. 
“Classic porins” of other Gram-negative bacteria are usually found as trimers in the outer 
membrane, although monomeric forms of porins are known as well (109, 124). These 
trimers have been reported to be extremely stable even in the presence of SDS and to 
dissolve only by heating above 60°C in SDS (76, 84). This is the case for most known 
porins, though exceptions from this rule like the unusually labile PorB-trimers of 
Neisseria gonorrhoeae exist, that dissolve in the presence of SDS at room temperature 
(89). MOMP of Chlamydiaceae is also present in a trimeric conformation in the outer 
membrane and trimers of this proteins only dissociate upon heating to 95°C (74). The 
band found at 55 kDa in Western blots with purified pc1489 could represent the trimeric 
form of pc1489, because due to the unusual binding of SDS trimers of other porins of 
Gram-negative bacteria migrate with a molecular mass of 65 to 70 kDa on SDS-PAGE 
gels (13). If pc1489 is present as trimer in the outer membrane of P. amoebophila, it 
  4. Discussion 
 
  87 
could be unusually labile, because even for samples in buffer without DTT that were not 
heated, the band at 30 kDa, representing the monomer, was dominant. It is possible that 
multimers of pc1489 were destroyed during purification, although similar protocols are 
used for extraction of other porins and were not reported to destabilize these protein 
complexes. However, pc1489 trimers could be comparable to PorB of Neisseria 
gonorrhoeae and dissolve in the presence of SDS at room temperature. As in 
asynchronized cultures of amoebae infected with P. amoebophila the most prominent 
band is observed at around 55 kDa in Western blot analysis, this would support the 
presence of multimers of pc1489. However, these results suggest that multimers would 
then be quite stable as they were not broken by heating of samples to 95°C, but that the 
multimers would be somehow destroyed during purification of pc1489 from elementary 
bodies. 
If pc1489 is present as a monomer in contrast to MOMP of Chlamydiaceae, bands at 
higher molecular weight  could result from interactions with other proteins of the outer 
membrane, for example the cystein-rich proteins pc0616 and pc0617. This is supported 
by the finding that other outer membrane proteins were identified in the same bands as 
pc1489 by mass spectrometry (47). In order to further analyze the organization of pc1489 
in the outer membrane, cross linking experiments of outer membrane fractions should be 
performed. 
The putative function of pc1489 as a porin was confirmed by lipid bilayer measurements 
that showed a stepwise increase in conductance after addition of pc1489 to lipid bilayers, 
each step indicating incorporation of one pore into the membrane. The single-channel 
conductance for this porin was 3.25 nS in 1 M KCl and thereby considerably higher than 
those observed for the so-called “classic porin” OmpF of E. coli (0.7 nS) (89). It is also 
higher than single-channel conductance values observed for MOMPs of the 
Chlamydiaceae. MOMP of C. trachomatis and Chlamydophila psittaci have a single-
channel conductance of 1 nS and 1.5  
nS in 1 M KCl, respectively (57). This shows that major outer membrane proteins of 
members of the Chlamydiaceae differ from each other and porins from environmental 
chlamydiae in their porin activity. Values observed for porins of other Gram-negative 
bacteria range from 10 pS for Tsx of E. coli (11) up to extremes of 20 nS for the 
thermophilic bacterium Thermus thermophilus (70). 
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Porin Organism Configuration Single channel 
conductance in 
1 M KCl 
Size of pore Reference 
MOMP C. trachomatis Trimer 1 nS 2 nm (57, 110) 
MOMP C. psittaci Trimer 1.5 nS not known (57) 
OmpA E. coli Monomer 50-80 pS or 
260-320 pS* 
1 nm (109) 
OmpF E. coli Trimer 0.7 nS 1.2 nm (89) 
OmpG E. coli Monomer 0.81 nS** 1.2 nm (20) 
pc1489 P. amoebophila Monomer or 
Trimer 
3.25 nS not known  
PorB N. gonorrhoeae Trimer 1 nS*** 1.6 nm (76) 
Table 15: Characteristics of a few porins of gram-negative bacteria  
*the two different values presumbably correspond to two different conformational states of this porin 
** measured in 1 M NaCl 
*** measured in 200 mM NaCl 
 
Dependence of the single-channel conductance on the concentration of KCl was shown, 
indicating the presence of a wide water-filled pore formed by pc1489 in lipid bilayers, 
although the exact size of pore has not been determined. Formation of a wide pore has 
also been demonstrated for the major outer membrane proteins of C. psittaci and C. 
trachomatis (57). The pore formed by MOMP is proposed to have a diameter of 2 nm 
based on penetration rates of sugars of different sizes through MOMP in liposome 
swelling assays (110). With a proposed diameter of 2 nm, the pore formed by MOMP is 
considerably larger than channels formed by other Gram-negative bacteria. Diameters 
range from 0.3 nm for Tsx over 0.7 nm for OmpF and 1.2 nm for the large porin OmpG 
of E. coli (89, 107). 
The porin pc1489 was shown to be selective for anions with a Pc/Pa-ratio of 0.48 for KCl, 
similar to that measured for native MOMP (0.5) by Wyllie et al. (121). The same authors 
reported slight cation selectivity for a truncated recombinant MOMP of C. psittaci and C. 
pneumoniae  and for a full-length recombinant construct of C. psittaci and C. trachomatis 
in later studies (57, 122). They suggested that small proteins or molecules bound to the 
channel present in native preparations might have modified selectivity of MOMP in their 
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previous study (57). MOMPs of C. psittaci and C. trachomatis were shown to differ 
significantly in ion selectivity at certain KCl concentrations, again pointing out 
differences in this channel for different members of the Chlamydiaceae. Removal of the 
largest variable domain of MOMP, VS4, made the pore even more cation selective, 
suggesting that selectivity for cations or anions results from variable domains exposed to 
the surface (57). As these domains vary largely between different members of the 
Chlamydiaceae, this will result in different ion selectivities of MOMPs. Indeed, different 
selectivities were reported in other studies where cation selectivity (32) and no selectivity 
for anions or cations was reported (60). These variable results may not only result from 
different organisms used, but also from the use of native MOMP or different recombinant 
constructs in different studies. As it is quite difficult to express the full-length MOMP of 
some chlamydiae in E. coli, truncated constructs are often used, probably resulting in 
differences in folding of the protein and therefore other pore-forming characteristics. In 
this study, native pc1489 was used to determine selectivity for anions. Therefore, biased 
results due to recombinant expression can be excluded. 
As a family of four putative porins with an amino acid sequence identity of 22-28 % was 
identified in P. amoebophila, characterization of the other members of this family will be 
interesting. The three major porins of E. coli, OmpC, OmpF and PhoE share ~60 % 
homoloy and differ slightly in their ion-selectivity and pore size (77). The expression of 
ompC and ompF was shown to be regulated by the omsotic strength of the medium, 
whereas phoE is expressed under phosphate limitation (reviewed in 90). In C. 
trachomatis, a protein with 20.4% sequence identity to MOMP was identified. This 
protein, termed PorB, was only observed in small amounts in the COMC and a more 
specific function of this porin compared to MOMP was suggested (65). Similiarly, 
different members of the putative porin family of P. amoebophila could be expressed at 
different time points in the developmental cycle or differ in ion selectivity. Further 
analysis should be performed to show whether the other members of this family do indeed 
function as porins and how they differ from each other. 
To sum up, pc1489 was shown to be localized to the outer membrane of P. amoebophila, 
to be present during the whole developmental cycle of this organism and to function as 
porin in this study. 
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4.2 Influencing the infectivity of P. amoebophila 
4.2.1 Inhibition of infection by pre-incubation with antibodies 
It has been shown more than 40 years ago that incubation of chlamydiae with sera 
prepared against whole chlamydiae resulted in inhibition of infection of host cells by 
these organisms (e.g. 55). Caldwell and Perry  (16) were the first to show that incubation 
of EBs with antibodies targeting MOMP of C. trachomatis resulted in neutralization of 
infection of host cells. They reported that incubation of EBs with antibody did not 
influence the attachment or entry, but inhibition of infection occurred at a later time point 
in the infection cycle. Later studies using antibodies targeting MOMP resulted in either 
inhibition of attachment (106, 114) or in neutralization of infection at steps after 
internalization of the chlamydiae (92). The results of these studies suggest that different 
antibodies against MOMP, targeting different regions of this protein, lead to 
neutralization of infection at different time points. Prevention of attachment can be easily 
explained by masking of domains important for binding to host cells, comparable to 
reports about neutralization of infection by antibodies against the outer membrane 
proteins OmcB or PmpD (78, 115).  Neutralization at later time points is more difficult to 
explain. The study by Caldwell and Perry (16) also demonstrated that inhibition of 
infection after uptake of cells depended on the use of intact dimeric IgG molecules, 
because Fab fragments targeting MOMP did not neutralize infectivity. Based on this 
observation, they suggested that effects on infectivity of C. trachomatis could result from 
higher structural rigidity of the outer membrane due to cross linking by IgG, thereby 
preventing transformation of EBs to RBs or inhibiting transport of host-derived nutrients 
to the bacteria. Alternatively, they proposed that cross linking of MOMP by IgG 
molecules could restrict fluidity of the outer membrane and prevent other components of 
the outer membrane from interacting with host receptors (16). 
In contrast to the pronounced effects of incubation with anti-MOMP-antibody on 
infectivity of members of the Chlamydiaceae, no effect was observed on the infectivity of 
P. amoebophila after incubation with two different antibodies. Anti-Pam-antibody was 
raised against whole EBs of P. amoebophila. EBs that were incubated with this antibody 
were still taken up by host cells and were able to multiply within amoebae comparable to 
non-treated controls. No effect was observed for pre-incubation with antibodies targeting 
pc1489, a protein thought to be the functional replacement of MOMP in P. amoebophila. 
These results suggest that neither pc1489 nor proteins targeted by anti-Pam-antibody play 
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a role in attachment to amoeba host cells. P. amoebophila might attach to amoebae by 
means of other proteins that are not targeted by these antibodies, it might attach to 
amoebae by unspecific interactions (e.g. electrostatic) or might just be taken up by 
amoebae like other bacteria on which these protozoa feed.  
In addition, the obtained results show that multiplication is not blocked by treatment with 
antibodies in P. amoebophila in contrast to C. trachomatis (16) and therefore either no 
cross linking of the outer membrane occurs or cross linking does not influence outer 
membrane rigidity or fluidity. It is possible that cross linking is not as effective as in C. 
trachomatis, because pc1489 might not be as abundant in the outer membrane as MOMP 
that is thought to make up about 60% of the outer membrane of Chlamydiaceae (15). On 
the other hand, inhibition of infection has also been observed for pre-incbuation with 
antibodies targeting PorB, a porin of C. trachomatis that is present in the outer membrane 
in lower amounts than MOMP (65). 
Although differences in the abundance of pc1489 and MOMP could account for 
differences in inhibition of infection by antibodies targeting these proteins, finding an 
explanation for no observed effect by treatment with serum against P. amoebophila is 
more difficult.  
It was shown that EBs of C. psittaci treated with serum against this bacterium were taken 
up by macrophages and destroyed rapidly, because they lost the ability to prevent 
phagolysosomal fusion (123). In contrast, P. amoebophila EBs treated with anti-Pam-
antibody were not digested by amoebae, but multiplied within these cells. Therefore, P. 
amoebophila must be able to escape from the endocytic pathway even after blocking 
proteins of the outer membrane. These observations are similar to results obtained for the 
intracellular bacteria Legionella pneumophila and Coxiella burnettii. In both organisms, 
treatment with sera against these organisms does not inhibit intracellular multiplication 
(49, 54).  
In P. amoebophila, proteins in the inclusion membrane could participate in escape of the 
bacterium from the endocytic pathway. Inc proteins identified in P. amoebophila differ 
substantially from those of clinical chlamydiae (47) and therefore could account for 
differences in the ability to survive phagocytosis even after preincubation with antibodies. 
However, it can not be excluded that antisera used in this study did not crosslink outer 
membrane proteins of P. amoebophila in a way comparable to sera against C. psittaci or 
other members of the Chlamydiaceae.  
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Additionally, it has to be considered that A. castellanii Neff is not the native host of P. 
amoebophila. Maybe effects of antibody-treatment on infectivity would be observable in 
the native host. If outer membrane proteins of P. amoebophila are adapted to attachment 
to only the native host, they would not be required for uptake by A. castellanii. In this 
case, A. castellanii that feed on bacteria would take up this bacterium unspecifically. 
However, as the native host of P. amoebophila is not known yet, it is not possible to 
investigate this issue further at the moment. 
4.2.2 Inhibition of infection by heat-treatment 
Members of the Chlamydiaceae lose their infectivity upon heat treatment and heat-labile 
components of the outer membrane were suggested to be the cause for this, although 
slightly contradictory results were reported, maybe generated by different incubation 
conditions and different host cell lines used (14, 16, 33, 123) . 
Heat treatment resulted in loss of infectivity of P. amoebophila. Heat treated cells were 
taken up by amoebae comparable to non-treated control cells, but were not able to 
multiply. As no increase of Hsp60-signal, that is thought to be a sign of metabolically 
active cells, was observed for the treated cells, heat-inactivated EBs might be unable to 
convert to metabolically active RBs. Intriguingly, anti-Pam-signals for P. amoebophila 
cells were observed up to 96 h p.i. in amoebae and morphology of cells was preserved up 
to 72 hours. This stands in contrast to rapid destruction of heat treated C. psittaci in 
macrophages (123) and also to the fact that E. coli normally taken up by amoebae are 
digested within 72 hours (Illias Lagkouvardos, personal communication). The observation 
that heat inactivated chlamydiae are not immediately destroyed by amoebae is supported 
by a report by Greub (39) who found heat-inactivated P. acanthamoeba cells in 
macrophages as long as 48 hours post infection. Because this study also showed that the 
lysosomal hydrolase Cathepsin D, an enzyme involved in caspase activation, did not 
colocalize with heat-inactivated bacteria, Greub suggested a passive modulation of the 
intracellular fate of heat-inactivated P. acanthamoeba, maybe by a special composition of 
the bacterial outer membrane. As EBs were incubated for a longer period of time and at 
higher temperatures in the study by Greub in comparison to this study, this putative 
protective effect could be even more pronounced for treatment in this study and explain 
the observed results. 
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4.3 Inc-proteins of P. amoebophila 
Modification of the host-derived membrane of the inclusion by incorporation of 
chlamydial Inc-proteins was discovered more than 10 years ago (93). The exact role of 
most of these proteins for interactions with the host is not known, but they are considered 
as important means for the communication between host cell and chlamydiae, to play a 
role in transport of nutrients to the chlamydiae and to ensure survival of these bacteria 
within the host cell.  
Recently, an in silico approach identified 24 putative Inc-proteins in the genome of the 
chlamydia-like bacterium P. amoebophila (47). Only three of the predicted Inc-proteins 
showed some sequence similarity to proteins of the Chlamydiaceae and one, pc0399, 
showed weak sequence similarity to an inclusion membrane protein, IncA, of 
Chlamydiaceae (47). For four of these proteins, pc0399, pc0156, pc0530 and pc1111, 
localization in the inclusion membrane is supported by halo-shaped signals observed in 
immunofluorescence analysis. In addition, no signal was detected for these proteins in 
highly-purified EBs where no inclusion membrane should be present. Although additional 
proof concerning the localization of these proteins is needed, the obtained results and the 
presence of a large bilobed hydrophobicity motif, a key feature of known Inc-proteins, 
point to a localization of these proteins to the inclusion membrane. Transmission electron 
microscopy studies are in progress to show the exact localization of these proteins. 
Inc-proteins of P. amoebophila are of special interest, as this chlamydia-like bacterium 
resides within single-cell inclusions and the inclusions inhabited by this organism do not 
fuse in contrast to members of the Chlamydiaceae (19). As Inc-proteins and especially the 
IncA protein are thought to play an important role in the fusion of inclusions, probably by 
means of a SNARE-like motif recently identified in IncA (27) that is not present in 
pc0399, differences between Inc-proteins of P. amoebophila and Chlamydiaceae could 
help to a better understanding of the function of these proteins. 
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5. Summaries 
5.1 Summary 
Proteins in the outer membrane of chlamydiae are of great importance as they are 
involved in attachment to host cells, uptake of nutrients, removal of waste and also in the 
differentness of the two developmental stages of chlamydiae. Therefore and because of 
their potential as vaccine candidates, these proteins have been studied extensively for 
members of the Chlamydiaceae. Sequencing of the genome of the first member of the 
environmental chlamydiae, the amoeba endosymbiont Protochlamydia amoebophila, 
showed that no gene similar to the most abundant outer membrane protein of the 
Chlamydiaceae, the major outer membrane protein (MOMP), is encoded (19). In a recent 
study, a family of putative porins was identified in the genome of P. amoebophila. Two 
of these porins were found to be highly abundant on 2D gels of outer membrane 
preparations of this organism and predicted to form beta-barrels by in silico analysis (47). 
In this study, the putative porin pc1489 was purified from elementary bodies of P. 
amoebophila and antibodies were raised against this protein. The localization of pc1489 
to the outer membrane was confirmed by immunofluorescence analysis and immuno-
transmission electron microscopy. It was shown that the protein is present throughout the 
whole developmental cycle, thereby indicating an important role of this protein for P. 
amoebophila. Its function as a porin was confirmed by lipid bilayer measurements using 
purified pc1489. These measurements showed that the pore formed by pc1489 is quite 
large and anion selective. These results suggest that pc1489 might be the functional 
replacement of MOMP in P. amoebophila, possibly together with other members of the 
putative porin family. However, in contrast to MOMP, preincubation of EBs with 
antibodies targeting pc1489 as well as antibodies against the immunodominant 
components of the outer membrane did not inhibit infection of host cells by P. 
amoebophila.  
In the second part of this diploma thesis, the localization of putative inclusion proteins in 
P. amoebophila was studied. Four of the five proteins studied where shown to be 
localized to either the outer membrane or the inclusion membrane of P. amoebophila by 
immunofluorescence analysis. Although the function of these proteins is not known yet, 
they are suggested to play an important role in communication between symbiont and 
host and also in survival of P. amoebophila after internalization by amoebae.  
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5.2 Zusammenfassung 
 
Außenmembranproteine spielen eine wichtige Rolle für Chlamydien, da sie für die 
Bindung an Wirtszellen, die Aufnahme von Nährstoffen in die Zelle und die Entfernung 
von Stoffwechselendprodukten benötigt werden und zusätzlich zu Unterschieden 
zwischen den beiden Entwicklungsstadien der Chlamydien beitragen. Da sie viel 
versprechende Kandidaten für die Entwicklung von Impfstoffen sind, sind die 
Außenmembranproteine der Chlamydiaceae gut erforscht. Im Gegensatz dazu ist wenig 
über diese Proteine in der kürzlich entdeckten Gruppe der Umweltchlamydien bekannt. 
Im ersten sequenzierten Genom eines Vertreters dieser Gruppe, Protochlamydia 
amoebophila, wurde kein Homolog für das häufigste Außenmembranprotein der 
Chlamydiaceae, das Major outer membrane protein, gefunden (19). Vor kurzem wurde 
eine Familie von putativen Porinen in P. amoebophila gefunden. Zwei dieser Proteine, 
pc1489 und pc1077, waren in großen Mengen auf 2D-Gelen mit 
Außenmembranfraktionen vorhanden (47). 
In dieser Diplomarbeit wurde das putative Porin pc1489 aus Elementarkörpern 
aufgereinigt und Antikörper gegen dieses Protein hergestellt. Unter Verwendung dieser 
Antikörper wurde mittels Immunfluoreszenzanalyse und 
Transmissionselektronenmikroskopie gezeigt, dass pc1489 in der Außenmembran von P. 
amoebophila lokalisiert ist. Pc1489 konnte während des gesamten Entwicklungszyklus in 
der Außenmembran von P. amoebophila detektiert werden, was auf eine wichtige Rolle 
dieses Proteins hinweist. Lipid Bilayer Messungen zeigten, dass pc1489 tatsächlich die 
Funktion eines Porins besitzt und große, anionen-selektive Proteine in Lipidmembranen 
formt. Diese Ergebnisse deuten darauf hin, dass pc1489 in P. amoebophila das Major 
outer membrane protein ersetzen könnte, möglicherweise gemeinsam mit anderen 
Mitgliedern der putativen Porinfamilie. 
Im zweiten Teil dieser Diplomarbeit wurden putative Inklusionsproteine von P. 
amoebophila bezüglich ihrer Lokalisation untersucht. Immunfluoreszenzanalyse mit 
Antikörpern gegen diese Proteine zeigte, dass 5 der 4 untersuchten  Proteine entweder in 
der Außenmembran oder der Inklusionsmembran von P. amoebophila lokalisiert sind. 
Obwohl die Funktion dieser Proteine noch nicht bekannt ist, wird vermutet, dass sie eine 
wichtige Rolle in der Kommunikation mit der Wirtszelle spielen und dadurch auch den 
Verdau dieser Bakterien durch Amöben verhindern könnten. 
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λ   Wavelength   
16S rRNA  Small ribosomal RNA subunit of prokaryotes 
1D   One dimensional 
2D   Two dimensional 
A   Adenine 
A.   Acanthamoeba 
ABC  Ammonium bicarbonate 
ACN  Acetonitrile 
Amp  Ampicillin 
APS  Ammonium persulfate 
ATP  Adenosine-5'-triphosphate 
bp   Base pair(s) 
BSA  Bovine serum albumin 
C   Cytosine 
C.   Chlamydia 
CLSM  Confocal laser scanning microscope 
COMC  Chlamydia outer membrane complex 
Cy2 5,5`-di-sulfo.1,1`-di-(X-carbopentynyl)-3,3,3`,3`-tetra-methylindol-
Cy2.18-derivative N-hydroxysuccimidester 
Cy3 5,5`-di-sulfo.1,1`-di-(X-carbopentynyl)-3,3,3`,3`-tetra-methylindol-
Cy3.18-derivative N-hydroxysuccimidester 
Cy5 5,5`-di-sulfo.1,1`-di-(X-carbopentynyl)-3,3,3`,3`-tetra-methylindol-
Cy5.18-derivative N-hydroxysuccimidester 
Da   Dalton 
DAPI  4',6-Diamidino-2-phenylindol 
DIC  Differential interference contrast 
DDT  Dithiothreitol 
DNA  Desoxyribonucleic acid 
dNTP  Desoxynucleotide triphosphate 
E.   Escherichia 
EB(s)  Elementary body (-ies) 
e.g.  example given 
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et al.  Et alterti (lat. and others) 
EtOH  Ethanol 
Fig.  Figure 
FITC  Fluorescein isothiocyanate 
g   Gram(s); gravity 
GTP  Guanosine-5'-triphosphate   
h   Hours 
H2Odd  Double distilled water 
h p.i.  hours post infection 
HCl  hydrochloric acid 
His  Histidine 
HRP  Horseraddish-Peroxidase 
Hsp  Heat shock protein 
Ig   Immunglobulin 
Inc   Inclusion 
IPTG  Isopropyl-β-D-thiogalactopyranosid 
k   Kilo 
KCl  Kalium chloride 
L   Liter(s) 
LB   Luria Bertani 
LC   Liquid chromatography 
LiCl  Lithium chloride 
µ   Mikro 
m   Meter(s); milli 
M   Molar 
MALDI  Matrix-assisted laser desorption/ionization 
mg   Milligramm 
min  Minute(s) 
MOI  Multiplicity of infection 
MOMP  Major outer membrane protein 
MS  Mass spectrometry 
MS/MS  Tandem mass spectrometry 
n   Nano 
NaCl  Sodium chloride 
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NaOH  Sodium hydroxide 
P. Parachlamydia; Protochlamydia 
Pa Permeability coefficient for an anion 
Pc    Permeability coefficient for a cation 
PAGE  Polyacrylamide gel electrophoresis 
PCR  Polymerase chain reaction  
PFA  Paraformaldehyde 
PMP  Polymorphic outer membrane protein 
RB(s)  Reticulate body (-ies) 
RFLP  Restriction fragment length polymorphism 
RNA  Ribonucleic acid 
rpm  Revolutions per minute 
rRNA  Ribosomal RNA 
RT   Room temperature 
S   Siemens 
SDS  Sodium dodecyl sulfate 
sec   Second(s); section 
SNARE  Soluble N-ethylmaleimide-sensitive factor attachment protein 
receptors 
sp.   Species 
T   Thymine 
TEMED  N,N,N´,N´-tetramethylethane-1,2-diamine  
Tris  Trishydroxymethylaminomethane 
TSY  Trypticase Soy Broth with Yeast Extract 
UK  United Kingdom 
USA  United States of America 
UV  Ultraviolet 
V   Volt 
v/v   Volume per volume 
W   Watt 
w/v  Weight per volume 
w/w  Weight per weight 
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